connective tissue disease: A disorder characterized by abnormalities in one or more of the elements of the connective tissues, typically associated with genetic defects.
Other specified/unspecified systemic involvement of connective tissue
DOID EFO Endpoint Browser PheWeb
M13_CONNECTNAS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2270 |
4. Check minimum number of eventsNone |
2270 |
5. Include endpointsNone |
2270 |
6. Filter based on genotype QC (FinnGen only) |
2270 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other specified/unspecified systemic involvement of connective tissue
based on the number of shared cases.
Similar with more cases:
- Other systemic involvement of connective tissue (FG)
- Other systemic involvement of connective tissue
- Systemic connective tissue disorders
- Finngen Rheumatological endpoints
- Diseases of the musculoskeletal system and connective tissue
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 14013 | 10660 | 3215 |
| Only index persons | 11603 | 9189 | 2414 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.25 | 0.31 | 0.09 |
| Only index persons | 0.29 | 0.34 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 52.98 | 51.92 | 56.35 |
| Only index persons | 50.88 | 50.14 | 53.68 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2270 | 1802 | 468 |
| Unadjusted period prevalence (%) | 0.53 | 0.61 | 0.21 |
| Median age at first event (years) | 50.21 | 48.62 | 56.33 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2074
- Matched controls
- 20737
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P01BA02
ATC
hydroxychloroquine; oral
36.2
323.0
1216
781
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
440.1
323.0
445
13
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4503599627370496.0
323.0
1733
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
19.2
323.0
1086
1123
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
3086.1
297.0
280
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
12.2
288.1
566
618
H02AB06
ATC
prednisolone; systemic
5.5
274.8
1522
6899
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
8.6
254.4
618
970
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
+∞
217.6
205
*
L04AX01
ATC
azathioprine; systemic
13.2
205.3
380
347
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
186.3
176
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.7
164.1
1085
4761
I73.0
ICD-10 Finland
Raynaud syndrome
25.1
155.8
223
99
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
7.0
147.9
398
676
C08CA05
ATC
nifedipine; systemic
6.9
130.5
354
601
XPX04
NOMESCO Finland
Angioscopy
146.6
129.9
137
10
M35.3
ICD-10 Finland
Polymyalgia rheumatica
20.7
127.6
194
103
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
121.9
1126
5857
XX9XE
NOMESCO Finland
Other ultrasound examination
40.0
112.1
142
38
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
+∞
103.0
98
*
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
11.8
100.7
192
177
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.7
97.3
368
909
H02AB07
ATC
prednisone; oral
3.6
96.0
508
1701
M34.1
ICD-10 Finland
CR(E)ST syndrome
938.9
92.6
90
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
7.2
90.5
232
355
L04AA06
ATC
mycophenolic acid; systemic
17.7
88.3
141
85
73491
ICD-8 Finland
Diffuse diseases of connective tissue, Collagenosis NUD
+∞
87.1
83
*
L88
ICPC
Rheumatoid/seropositive arthritis
7.1
86.0
223
346
7109X
ICD-9 Finland
Diffuse diseases of connective tissue, Unspecified diffuse connective tissue disease
+∞
83.9
80
*
M05BA04
ATC
alendronic acid; oral
4.4
82.6
332
862
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.8
80.0
290
677
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.2
79.8
228
403
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
79.7
76
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
76.7
756
3757
M25.5
ICD-10 Finland
Pain in joint
2.5
74.9
780
3987
M79.0
ICD-10 Finland
Rheumatism, unspecified
6.5
73.0
201
337
H04.10
ICD-10 Finland
Dry eye syndrome
3.7
70.4
346
1067
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
5.1
69.4
234
502
SBA10
NOMESCO Finland
Measurement of excretion of saliva
15.9
65.8
109
72
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.7
64.8
319
980
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
63.9
61
*
M13.9
ICD-10 Finland
Arthritis, unspecified
4.1
62.2
261
696
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.2
61.7
1023
6386
R50.9
ICD-10 Finland
Fever, unspecified
2.9
55.1
394
1571
A02BC02
ATC
pantoprazole; systemic
2.1
54.6
1429
10598
M35.7
ICD-10 Finland
Hypermobility syndrome
30.2
54.4
73
25
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
8.3
54.1
124
158
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
53.4
51
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
+∞
52.3
50
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
52.2
548
2707
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.4
50.9
275
900
ZX120
NOMESCO Finland
Intravenous
3.2
49.2
283
968
R06.0
ICD-10 Finland
Dyspnoea
2.2
48.5
597
3168
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
6.0
48.1
139
246
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
47.2
480
2316
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.1
45.1
273
964
N03AX16
ATC
pregabalin; oral
2.2
44.9
568
3030
UJF32
NOMESCO Finland
Coloscopy
2.2
44.7
593
3232
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.9
43.1
191
529
N02AX02
ATC
tramadol; systemic, rectal
1.9
42.7
911
5983
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
9.1
42.4
91
104
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.4
42.1
437
2114
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
6.1
41.0
116
200
M34.0
ICD-10 Finland
Progressive systemic sclerosis
+∞
40.8
39
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.8
40.7
119
214
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
89.9
39.9
44
5
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.1
39.6
243
863
R4120
NOMESCO Finland
Occupational therapy
3.6
38.9
190
570
PAW37
NOMESCO Finland
Biopsy of temporal artery
52.2
38.7
46
9
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.6
38.6
319
1363
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
38.4
326
1415
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
38.1
486
2575
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
7.6
37.6
90
123
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.0
36.9
237
865
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
101.9
36.8
40
*
L04AD01
ATC
ciclosporin; systemic
7.6
36.3
87
119
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
6.8
35.7
92
140
E0000UV
ATC
NA
1.8
35.7
870
5872
A07EC01
ATC
sulfasalazine; oral, rectal
2.9
35.3
235
879
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
59.7
35.3
41
7
M33.2
ICD-10 Finland
Polymyositis
183.1
34.8
36
*
C03CA01
ATC
furosemide; systemic
2.0
34.6
547
3151
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
+∞
34.5
33
*
M79.7
ICD-10 Finland
Fibromyalgia
4.2
34.4
138
349
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.5
34.4
168
504
A02BC03
ATC
lansoprazole; oral
1.9
34.2
669
4167
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
122.1
33.8
36
*
H02AB04
ATC
methylprednisolone; systemic
2.2
33.6
374
1850
7108X
ICD-9 Finland
Diffuse diseases of connective tissue, Other specified diffuse diseases of connective tissue
+∞
33.4
32
*
M32
ICD-10 Finland
Systemic lupus erythematosus
172.7
32.8
34
*
XG410
NOMESCO Finland
Flow-volume spirometry
4.1
32.7
133
341
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.5
32.5
279
1211
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
32.1
293
1313
TEA00
NOMESCO Finland
Biopsy of lip
10.8
32.0
62
59
M35.5
ICD-10 Finland
Multifocal fibrosclerosis
321.8
31.9
32
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.9
31.9
92
163
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.2
31.5
100
199
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.8
31.4
141
394
L93.0
ICD-10 Finland
Discoid lupus erythematosus
18.9
31.4
48
26
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
6.3
31.4
85
139
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
31.3
847
5837
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
8.0
31.3
72
93
N03AX12
ATC
gabapentin; oral
2.2
31.3
361
1813
J01MA12
ATC
levofloxacin; systemic
2.1
31.3
397
2079
M01AH01
ATC
celecoxib; oral (coxibs)
2.1
31.1
432
2347
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
31.1
457
2542
TGC00
NOMESCO Finland
Bronchial lavation
5.6
30.8
92
170
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
8.0
30.8
71
92
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.6
30.6
244
1013
ELA30
NOMESCO Finland
Biopsy of salivary gland
38.7
30.3
38
10
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
4.6
30.2
109
249
M05BA07
ATC
risedronic acid; oral
4.3
29.8
116
285
L04AA01
ATC
[U] ciclosporin; systemic
8.4
29.6
66
81
J01FF01
ATC
clindamycin; systemic
1.8
29.4
590
3669
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
28.6
183
665
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
28.2
220
901
L04AA13
ATC
leflunomide; oral
4.5
27.9
102
236
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
285.2
27.8
28
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
27.7
366
1936
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
9.4
27.5
57
62
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
27.3
347
1806
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
5.4
27.2
83
158
A02BC01
ATC
omeprazole; systemic
1.8
27.0
587
3729
M05BX04
ATC
denosumab; parenteral
3.3
26.8
140
442
N02BE01
ATC
paracetamol; systemic, rectal
1.9
26.7
1776
15659
L99
ICPC
Musculoskeletal disease other
6.0
26.7
75
129
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
46.4
26.5
32
7
R51.80
ICD-10 Finland
Headache
2.1
26.3
352
1868
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.3
25.9
135
425
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
25.6
377
2081
M33.1
ICD-10 Finland
Other dermatomyositis
+∞
25.0
24
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
24.8
799
5678
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
24.8
751
5247
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
24.1
214
939
GD1AD
NOMESCO Finland
Thorax CT examination
3.6
24.1
112
323
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.5
24.0
117
350
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
24.0
23
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
23.7
531
3382
N06AX21
ATC
duloxetine; oral
2.2
23.4
253
1223
J01DB01
ATC
cefalexin; oral
1.7
23.2
1655
14417
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
23.1
925
6922
A07AA02
ATC
nystatin; oral
2.7
23.1
168
661
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
4.9
23.0
77
163
NXL00
NOMESCO Finland
Biopsy of muscle
22.3
23.0
33
15
73498
ICD-8 Finland
Diffuse diseases of connective tissue, Alii definiti
+∞
23.0
22
*
P01BA01
ATC
chloroquine; systemic
15.7
22.8
37
24
N06AA09
ATC
amitriptyline; systemic
2.2
22.7
244
1175
M35
ICD-10 Finland
Other systemic involvement of connective tissue
121.4
22.6
24
*
ZX140
NOMESCO Finland
Intra articular
8.9
22.1
47
54
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.0
22.1
134
471
J01MA14
ATC
moxifloxacin; systemic
2.4
21.7
203
913
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
6.4
21.6
57
91
M01AC06
ATC
meloxicam; systemic, rectal
1.6
21.5
769
5560
J01FA06
ATC
roxithromycin; oral
1.6
21.5
850
6307
A02BC05
ATC
esomeprazole; systemic
1.6
21.4
839
6208
M79.1
ICD-10 Finland
Myalgia
2.0
21.4
295
1576
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
21.4
601
4070
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
17.6
21.3
33
19
D68.8
ICD-10 Finland
Other specified coagulation defects
7.5
21.2
50
68
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.2
21.2
81
197
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
21.2
380
2239
M05BB03
ATC
alendronic acid and colecalciferol; oral
4.3
21.0
79
189
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.7
20.9
150
582
J02AC01
ATC
fluconazole; systemic
1.6
20.9
941
7191
J01DA01
ATC
[U] cefalexin; systemic
1.6
20.9
1286
10590
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.2
20.9
80
195
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
+∞
20.9
20
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.0
20.7
126
444
J01MA02
ATC
ciprofloxacin; systemic
1.6
20.7
733
5276
C08CA02
ATC
felodipine; oral
2.3
20.6
197
896
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
22.6
20.4
29
13
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.5
20.3
161
665
NF1AA
NOMESCO Finland
Hip X-ray examination
2.4
20.3
186
829
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.1
20.2
238
1191
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
20.2
191
864
R03AC02
ATC
salbutamol; inhalant
1.5
20.0
1073
8509
73499
ICD-8 Finland
Diffuse diseases of connective tissue, Other and unspecified
+∞
19.8
19
*
C07AB07
ATC
bisoprolol; oral
1.6
19.7
852
6414
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
19.7
175
767
318
Kela drug reimbursment
Teriparatide
13.3
19.7
34
26
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
19.7
218
1060
K90.0
ICD-10 Finland
Coeliac disease
3.8
19.3
84
230
A02BA02
ATC
ranitidine; systemic
1.8
19.3
398
2447
M79.6
ICD-10 Finland
Pain in limb
1.6
19.2
713
5162
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.7
19.0
85
238
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
19.0
664
4737
M01AH02
ATC
rofecoxib; oral
2.0
19.0
282
1547
M60.9
ICD-10 Finland
Myositis, unspecified
12.9
18.9
33
26
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
8.8
18.9
40
46
C08CA01
ATC
amlodipine; oral
1.6
18.8
637
4502
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
18.8
18
*
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
8.8
18.4
39
45
S18
ICPC
Laceration/cut
1.5
18.3
780
5821
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
18.3
154
656
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
6.4
18.2
48
77
H26.3
ICD-10 Finland
Drug-induced cataract
11.1
18.2
34
31
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
3.4
18.2
89
269
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.5
17.9
145
604
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
17.8
355
2155
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
17.7
17
*
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
+∞
17.7
17
*
WZA10
NOMESCO Finland
Long statement of health and health related matters
5.6
17.5
51
93
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.0
17.5
242
1290
J01AA02
ATC
doxycycline; systemic
1.6
17.4
1580
13902
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.3
17.4
168
768
M81.4
ICD-10 Finland
Drug-induced osteoporosis
14.0
17.3
29
21
M54.5
ICD-10 Finland
Low back pain
1.6
17.3
655
4741
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
17.2
309
1810
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.3
17.2
164
746
R4110
NOMESCO Finland
Physiotherapy
1.6
17.1
510
3474
H05AA02
ATC
teriparatide; parenteral
13.3
17.0
29
22
R06AE07
ATC
cetirizine; oral
1.5
16.9
913
7147
R52.2
ICD-10 Finland
Other chronic pain
3.4
16.7
83
254
G73.7
ICD-10 Finland
Myopathy in other diseases classified elsewhere
+∞
16.7
16
*
7102A
ICD-9 Finland
Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]
+∞
16.7
16
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.9
16.7
68
177
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
90.8
16.6
18
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.2
16.5
181
877
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
16.4
325
1963
L50.9
ICD-10 Finland
Urticaria, unspecified
3.0
16.1
95
329
XW000
NOMESCO Finland
Bone marrow biopsy
3.1
16.1
91
304
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.1
16.0
89
296
L28
ICPC
Limited function/disability (L)
1.8
16.0
290
1704
N35.9
ICD-10 Finland
Urethral stricture, unspecified
9.5
15.9
32
34
K74.3
ICD-10 Finland
Primary biliary cirrhosis
9.5
15.9
32
34
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.5
15.9
75
221
A01AB09
ATC
miconazole; local oral
2.0
15.8
202
1045
ZXA00
NOMESCO Finland
Right side
1.6
15.8
513
3562
D07AC01
ATC
betamethasone; topical
1.5
15.8
652
4793
XQ860
NOMESCO Finland
Laser Doppler measurement/scan of capillary perfusion
+∞
15.6
15
*
K11.2
ICD-10 Finland
Sialoadenitis
3.1
15.4
84
276
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
15.3
322
1981
ELB10
NOMESCO Finland
Excision of minor salivary gland
16.2
15.2
24
15
L01AA01
ATC
cyclophosphamide; systemic
16.2
15.2
24
15
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
28.8
15.2
20
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
15.2
247
1398
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.1
15.1
171
840
G04BE03
ATC
sildenafil; oral
7.2
15.1
36
51
J01EA01
ATC
trimethoprim; systemic
1.5
15.0
547
3895
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
15.0
151
704
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
4.8
14.9
49
104
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
14.8
216
1172
R13
ICD-10 Finland
Dysphagia
2.3
14.6
133
591
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
12.0
14.6
26
22
N02AA05
ATC
oxycodone; systemic
1.8
14.5
252
1456
M01AX17
ATC
nimesulide; oral
1.6
14.5
473
3274
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
5.5
14.5
42
77
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
5.7
14.5
41
73
E000001
ATC
NA
1.6
14.5
416
2791
S01XA18
ATC
ciclosporin; ophthalmic
8.5
14.5
31
37
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
14.5
316
1966
M01AH05
ATC
etoricoxib; oral
1.4
14.4
1147
9592
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.3
14.4
73
228
J05AB01
ATC
aciclovir; systemic
1.6
14.3
435
2958
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.4
14.3
128
562
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.1
14.3
158
767
J05AB11
ATC
valaciclovir; oral
1.8
14.3
277
1661
A01
ICPC
Pain general/multiple sites
2.1
14.2
165
819
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
14.2
237
1352
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
4.5
14.2
50
114
R07.3
ICD-10 Finland
Other chest pain
2.0
14.1
193
1022
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
14.1
220
1226
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
14.1
483
3382
R76.0
ICD-10 Finland
Raised antibody titre
12.0
14.1
25
21
M01AB55
ATC
diclofenac, combinations; oral
2.2
14.1
142
661
K07.60
ICD-10 Finland
Snapping jaw
2.4
14.0
122
531
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
14.0
278
1678
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
11.0
14.0
26
24
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
14.0
419
2840
L95
ICPC
Osteoporosis
3.1
13.9
77
256
M48.0
ICD-10 Finland
Spinal stenosis
1.9
13.9
209
1147
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
13.9
136
625
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
13.8
848
6728
TNG10
NOMESCO Finland
Puncture of knee
5.8
13.8
38
66
B01AB05
ATC
enoxaparin; parenteral
1.5
13.7
566
4132
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
13.7
214
1191
R00.2
ICD-10 Finland
Palpitations
2.1
13.6
158
783
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
12.1
13.6
24
20
M35.4
ICD-10 Finland
Diffuse (eosinophilic) fasciitis
+∞
13.6
13
*
286
Kela drug reimbursment
Ciclosporin eye drop
+∞
13.6
13
*
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.7
13.5
95
367
M01AX01
ATC
nabumetone; oral
2.5
13.4
103
419
R03AC03
ATC
terbutaline; inhalant
1.7
13.4
287
1770
R53
ICD-10 Finland
Malaise and fatigue
1.6
13.4
392
2637
A02BX02
ATC
sucralfate; oral
2.6
13.4
98
386
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.7
13.3
275
1681
TAB00
NOMESCO Finland
Lumbar puncture
2.6
13.3
99
397
M05BA06
ATC
ibandronic acid; systemic
3.7
13.2
57
157
1XC02
NOMESCO Finland
NA
9.1
13.2
27
30
M01AE02
ATC
naproxen; oral, rectal
1.4
13.2
1110
9305
XF404
NOMESCO Finland
Ambulatory ECG
2.0
13.2
178
940
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
13.2
172
897
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.2
13.1
141
677
SPAT1229
SPAT
Assessment of need for aid
2.1
13.0
152
758
XF402
NOMESCO Finland
ECG with work load test
1.9
13.0
205
1144
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
2.3
13.0
120
538
R1250
NOMESCO Finland
Evaluation of functional capability
3.5
12.9
59
171
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.3
12.9
116
511
A01AB04
ATC
amphotericin B; local oral
2.4
12.8
106
450
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
12.8
160
818
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.3
12.7
64
200
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
12.7
1359
11873
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.9
12.6
195
1082
JN4BD
NOMESCO Finland
Extensive body CT
1.9
12.6
200
1117
M01CB03
ATC
auranofin; oral
6.5
12.6
32
50
R42
ICD-10 Finland
Dizziness and giddiness
1.6
12.6
392
2673
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.0
12.6
155
788
G44.2
ICD-10 Finland
Tension-type headache
1.7
12.6
276
1715
G05.8*M32.1
ICD-10 Finland
Encephalitis in systemic lupus erythematosus
+∞
12.5
12
*
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
12.5
12
*
M35.2
ICD-10 Finland
Behçet disease
+∞
12.5
12
*
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
17.4
12.5
19
11
SBB10
NOMESCO Finland
Teeth copy
2.2
12.5
127
595
M01CB01
ATC
sodium aurothiomalate; parenteral
4.4
12.5
44
101
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.6
12.5
90
355
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.1
12.4
134
646
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
5.6
12.4
35
63
UJF92
NOMESCO Finland
Capsular endoscopy
3.6
12.4
55
156
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
12.3
200
1129
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.0
12.3
161
837
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
12.3
269
1669
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
12.3
243
1463
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
12.3
201
1137
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.7
12.3
303
1947
WX110
NOMESCO Finland
Local anesthesy
1.4
12.3
1327
11570
H02AB09
ATC
hydrocortisone; systemic
3.3
12.2
60
184
XA402
NOMESCO Finland
ENMG
3.2
12.2
64
206
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
12.1
373
2535
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
12.1
318
2075
N02AC04
ATC
dextropropoxyphene; oral
2.7
12.1
83
317
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.9
12.1
48
124
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.3
11.9
59
182
Z01.2
ICD-10 Finland
Dental examination
1.4
11.9
782
6229
ZXA05
NOMESCO Finland
Left side
1.5
11.8
461
3310
RT272
NOMESCO Finland
NA
9.7
11.7
23
24
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.0
11.6
45
114
M70.6
ICD-10 Finland
Trochanteric bursitis
1.7
11.5
249
1539
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
4.2
11.5
43
105
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.9
11.5
69
244
A03FA02
ATC
cisapride; oral, rectal
2.0
11.5
155
818
G72.9
ICD-10 Finland
Myopathy, unspecified
10.1
11.5
22
22
L20
ICPC
Joint symptom/complaint NOS
2.6
11.5
85
341
M30.0
ICD-10 Finland
Polyarteritis nodosa
+∞
11.5
11
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.5
11.5
87
353
M34
ICD-10 Finland
Systemic sclerosis
120.7
11.4
12
*
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.0
11.4
138
698
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
11.4
279
1784
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
11.4
345
2333
5BA08
NOMESCO Finland
NA
8.4
11.3
24
29
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
4.4
11.3
40
93
-1
NOMESCO Finland
NA
1.4
11.3
622
4784
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.7
11.2
75
283
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
11.1
676
5289
A02BA04
ATC
nizatidine; systemic
2.0
11.1
150
791
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
11.1
700
5514
J45.1
ICD-10 Finland
Nonallergic asthma
2.0
11.1
141
726
WX002
NOMESCO Finland
Sedation and analgesia
1.6
11.0
358
2460
R11
ICD-10 Finland
Nausea and vomiting
1.9
11.0
155
832
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.4
11.0
52
156
I27.0
ICD-10 Finland
Primary pulmonary hypertension
14.0
11.0
18
13
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
6.7
11.0
27
41
J01FA10
ATC
azithromycin; systemic
1.4
10.9
1148
9858
C02KX01
ATC
bosentan; oral
43.5
10.9
13
*
AA1AD
NOMESCO Finland
CT of head and brain
1.5
10.8
397
2802
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
4.4
10.8
38
88
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
10.8
431
3103
RT271
NOMESCO Finland
NA
17.9
10.7
16
9
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.3
10.7
102
464
AN1
HP
Coronary angiography
1.8
10.7
177
1005
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
10.7
228
1403
D02AE01
ATC
carbamide; topical
2.0
10.7
132
673
M06
ICD-10 Finland
Other rheumatoid arthritis
7.6
10.7
24
32
R05
ICD-10 Finland
Cough
1.5
10.7
361
2505
L17
ICPC
Foot/toe symptom/complaint
1.5
10.6
454
3315
R76.8
ICD-10 Finland
Other specified abnormal immunological findings in serum
60.3
10.6
12
*
J45.8
ICD-10 Finland
Mixed asthma
2.8
10.6
66
238
SPAT1255
SPAT
Intravenous administration of medicine
2.1
10.6
118
576
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
2.8
10.6
68
252
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.1
10.6
114
551
N03AE01
ATC
clonazepam; systemic
2.1
10.5
118
580
L04AB01
ATC
etanercept; parenteral
4.0
10.5
41
105
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
4.6
10.5
35
77
C02KX04
ATC
macitentan; oral
110.6
10.4
11
*
L87.1
ICD-10 Finland
Reactive perforating collagenosis
+∞
10.4
10
*
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
+∞
10.4
10
*
J99.1*M35.0
ICD-10 Finland
Respiratory disorders in sicca syndrome [Sjögren]
+∞
10.4
10
*
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
10.4
10
*
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
+∞
10.4
10
*
7102B
ICD-9 Finland
Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM SECUNDARIUM]
+∞
10.4
10
*
B02.9
ICD-10 Finland
Zoster without complication
2.1
10.4
115
562
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.6
10.3
314
2122
XG460
NOMESCO Finland
Short time oxymetry
4.2
10.3
38
92
XQ848
NOMESCO Finland
Dermatological photography
3.0
10.3
59
201
S97
ICPC
Chronic ulcer skin
2.3
10.3
97
440
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
10.3
904
7506
D70.89
ICD-10 Finland
Neutropenic splenomegaly
4.4
10.3
36
83
M25.9
ICD-10 Finland
Joint disorder, unspecified
4.7
10.3
34
74
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.7
10.3
43
117
K59.1
ICD-10 Finland
Functional diarrhoea
2.2
10.3
102
475
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.7
10.2
201
1207
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
10.2
527
3987
A12BA01
ATC
potassium chloride; oral
2.4
10.2
83
351
A41.9
ICD-10 Finland
Sepsis, unspecified
2.9
10.2
61
217
A05AA02
ATC
ursodeoxycholic acid; oral
3.5
10.1
46
134
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
10.1
1224
10686
D07AD01
ATC
clobetasol; topical
1.6
10.1
294
1964
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
10.1
181
1057
P01AB01
ATC
metronidazole; oral, rectal
1.4
10.1
783
6371
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
2.0
10.0
121
612
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
10.0
948
7958
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.7
10.0
65
243
R20.2
ICD-10 Finland
Paraesthesia of skin
2.0
10.0
129
672
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
9.9
205
1249
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
9.9
519
3934
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.7
9.9
66
248
UKC02
NOMESCO Finland
Cystoscopy
1.7
9.9
232
1467
L12
ICPC
Hand/finger symptom/complaint
1.6
9.9
262
1709
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.3
9.9
92
417
EBA10
NOMESCO Finland
Surgical removal of tooth
1.7
9.9
201
1222
SPAT1301
SPAT
No procedures
1.4
9.8
562
4329
WX203
NOMESCO Finland
Infraclavicular plexus blockade
3.0
9.8
54
182
I77.6
ICD-10 Finland
Arteritis, unspecified
20.1
9.8
14
7
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
9.8
180
1060
Z01.9
ICD-10 Finland
Special examination, unspecified
2.1
9.7
110
542
WZA90
NOMESCO Finland
Other doctors statement
1.5
9.7
410
2980
E000006
ATC
NA
1.9
9.7
150
831
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
2.4
9.7
77
323
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
6.2
9.7
25
41
T78.4
ICD-10 Finland
Allergy, unspecified
2.2
9.7
98
462
N05CF01
ATC
zopiclone; oral
1.4
9.6
574
4454
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
9.6
299
2027
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.8
9.6
164
940
M05BA01
ATC
etidronic acid; systemic
6.8
9.6
23
34
Z50.1
ICD-10 Finland
Other physical therapy
2.1
9.6
111
553
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
4.6
9.6
32
71
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
11.4
9.6
17
15
S01GX01
ATC
cromoglicic acid; ophthalmic
1.5
9.5
391
2821
A28
ICPC
Limited function/disability NOS
1.6
9.5
233
1489
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
9.5
514
3915
M12.3
ICD-10 Finland
Palindromic rheumatism
15.1
9.5
15
10
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.8
9.5
149
833
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.2
9.5
96
449
R52.9
ICD-10 Finland
Pain, unspecified
1.8
9.5
158
902
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
9.5
117
599
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
9.5
141
774
M13.0
ICD-10 Finland
Polyarthritis, unspecified
4.0
9.4
36
91
XQ844
NOMESCO Finland
Other microscope or electron microscope examination
100.5
9.4
10
*
J01CA04
ATC
amoxicillin; systemic
1.4
9.4
1581
14465
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
30.2
9.4
12
*
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
4.6
9.4
31
68
J99.1*M32.1
ICD-10 Finland
Respiratory disorders in systemic: lupus erythematosus
+∞
9.4
9
*
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
5.3
9.4
27
51
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.3
9.3
83
368
J31.0
ICD-10 Finland
Chronic rhinitis
1.9
9.3
144
801
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
9.3
85
381
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
3.8
9.2
37
98
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.2
9.2
89
409
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
9.2
220
1399
6BA02
NOMESCO Finland
NA
13.7
9.2
15
11
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
9.1
221
1406
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.1
9.1
96
458
NDL52
NOMESCO Finland
Tenosynovectomy of hand
6.3
9.1
23
37
N06AX11
ATC
mirtazapine; oral
1.4
9.0
576
4515
K11.7
ICD-10 Finland
Disturbances of salivary secretion
36.8
9.0
11
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.8
9.0
36
95
J01FA09
ATC
clarithromycin; systemic
1.4
9.0
599
4728
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
3.4
9.0
41
121
K76.9
ICD-10 Finland
Liver disease, unspecified
3.5
9.0
40
116
R60.0
ICD-10 Finland
Localized oedema
1.7
8.9
192
1182
RT171
NOMESCO Finland
NA
18.7
8.9
13
7
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
3.6
8.9
38
106
M54.6
ICD-10 Finland
Pain in thoracic spine
1.9
8.9
121
642
RS221
NOMESCO Finland
NA
3.7
8.9
37
101
A46
ICD-10 Finland
Erysipelas
1.6
8.9
219
1402
ZX108
NOMESCO Finland
Inhalation
6.1
8.9
23
38
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.7
8.9
60
228
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.1
8.9
47
155
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
4.8
8.9
28
59
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
8.0
8.8
19
24
SPAT1263
SPAT
Sampling
1.3
8.8
771
6352
B07.9
ICD-10 Finland
Verruca simplex
2.5
8.7
67
276
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
8.7
129
705
M84.3
ICD-10 Finland
Stress fracture, not elsewhere classified
4.4
8.7
30
69
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
2.6
8.7
60
233
Z71.8
ICD-10 Finland
Other specified counselling
1.4
8.7
423
3151
SPAT1153
SPAT
Removal of sutures
1.4
8.7
552
4317
WW200
NOMESCO Finland
Immunization
2.8
8.7
52
186
ND1AE
NOMESCO Finland
Wrist ultrasound examination
7.7
8.6
19
25
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
5.0
8.6
26
52
R01AD09
ATC
mometasone; nasal
1.3
8.6
852
7144
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
8.6
477
3643
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.9
8.6
51
181
R01AD08
ATC
fluticasone; nasal
1.4
8.5
544
4256
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
4.4
8.5
29
66
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.4
8.5
40
121
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
8.5
593
4708
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
8.5
410
3051
A01AB10
ATC
natamycin; local oral
2.6
8.5
59
231
NH3AE
NOMESCO Finland
Feet ultrasound examination
6.4
8.5
21
33
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
8.5
973
8331
L94.9
ICD-10 Finland
Localized connective tissue disorder, unspecified
90.4
8.4
9
*
GDG10
NOMESCO Finland
Bilateral transplantation of lung
90.4
8.4
9
*
H03AA01
ATC
levothyroxine sodium; systemic
1.4
8.4
485
3727
D07AB08
ATC
desonide; topical
1.6
8.4
195
1231
L84
ICD-10 Finland
Corns and callosities
2.4
8.4
67
280
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
8.3
280
1933
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.8
8.3
151
884
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
8.3
205
1313
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
8.6
8.3
17
20
K11.70
ICD-10 Finland
Hypoptyalism
5.3
8.3
24
46
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
8.3
314
2223
N06AX16
ATC
venlafaxine; oral
1.5
8.2
259
1759
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.6
8.2
204
1306
C08DB01
ATC
diltiazem; oral
2.2
8.2
83
392
7290A
ICD-9 Finland
Other disorders of soft tissues, Rheumatism, unspecified and fibrositis
6.5
8.2
20
31
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
7.6
8.2
18
24
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
5.4
8.1
23
43
L01
ICPC
Neck symptom/complaint
1.5
8.1
249
1683
SPAT1254
SPAT
Administration of medicine
1.6
8.1
240
1610
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.1
8.0
88
428
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
8.0
1055
9186
UJD02
NOMESCO Finland
Gastroscopy
2.1
8.0
88
431
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.2
8.0
78
361
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
7.3
8.0
18
25
ZXA10
NOMESCO Finland
Bilateral
1.5
7.9
322
2315
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.5
7.9
59
241
B01AA03
ATC
warfarin; systemic
1.5
7.9
286
2005
M03BX02
ATC
tizanidine; oral
1.3
7.9
1189
10535
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.7
7.9
50
185
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
5.4
7.8
22
41
C07AB02
ATC
metoprolol; systemic
1.4
7.8
339
2466
D01AE16
ATC
amorolfine; topical
1.6
7.8
206
1341
L01CB
ATC
Podophyllotoxin derivatives
10.8
7.8
14
13
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
9.4
7.8
15
16
R03BA01
ATC
beclometasone; inhalant
1.5
7.7
258
1779
L30.8
ICD-10 Finland
Other specified dermatitis
2.7
7.7
50
188
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
7.7
242
1644
78890
ICD-8 Finland
Other general symptoms, Hypersedimentatio
45.1
7.7
9
*
4430A
ICD-9 Finland
Other peripheral vascular disease, Raynaud's syndrome
45.1
7.7
9
*
7199L
ICD-9 Finland
Other and unspecified disorder of joint, Unspecified disorder of joint[MB ARTICULI NUD,USEAT NIVELET]
15.1
7.7
12
8
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
7.7
180
1136
SBA00
NOMESCO Finland
Microbiological examinations
2.6
7.7
51
196
N30.0
ICD-10 Finland
Acute cystitis
1.5
7.6
261
1810
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.7
7.6
49
183
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.7
7.6
145
863
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.2
7.6
71
324
H19.3
ICD-10 Finland
Keratitis and keratoconjunctivitis in other diseases classified elsewhere
18.4
7.6
11
6
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
7.6
414
3145
R03BA08
ATC
ciclesonide; inhalant
1.7
7.6
163
1007
N35.0
ICD-10 Finland
Post-traumatic urethral stricture
25.1
7.6
10
*
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
7.6
724
6011
XA800
NOMESCO Finland
Neuropsychological investigation
2.2
7.6
73
337
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
7.6
541
4301
M45
ICD-10 Finland
Ankylosing spondylitis
2.9
7.6
44
155
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
5.2
7.5
22
43
G47.3
ICD-10 Finland
Sleep apnoea
1.4
7.5
317
2295
R03BB04
ATC
tiotropium bromide; inhalant
1.7
7.5
149
897
C03DA01
ATC
spironolactone; oral
1.6
7.5
170
1067
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
4.0
7.5
28
71
J47
ICD-10 Finland
Bronchiectasis
3.1
7.5
39
129
R01AD12
ATC
fluticasone furoate; nasal
1.3
7.4
545
4343
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.1
7.4
77
367
D02AX
ATC
Other emollients and protectives
2.2
7.4
68
309
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.8
7.4
129
746
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
7.4
109
598
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.0
7.4
86
430
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
4.1
7.4
27
67
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
6.0
7.4
19
32
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
2.4
7.4
58
243
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
7.4
120
682
R4190
NOMESCO Finland
Nutritional therapy
2.4
7.4
59
251
S01KA02
ATC
hypromellose; ophthalmic
2.9
7.4
43
152
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
7.4
1008
8777
NHQ40
NOMESCO Finland
Amputation of toe
3.8
7.4
29
77
L29.9
ICD-10 Finland
Pruritus, unspecified
2.6
7.3
49
189
XG466
NOMESCO Finland
Sleep oxymetry
2.4
7.3
56
233
RJ420
NOMESCO Finland
NA
8.4
7.3
15
18
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.8
7.3
128
743
N16.4*M35.0
ICD-10 Finland
Sjögren's syndrome with renal tubulo-interstitial disorders
+∞
7.3
7
*
G73.7*M32.1
ICD-10 Finland
Myopathy in systemic lupus erythematosus
+∞
7.3
7
*
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
+∞
7.3
7
*
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
+∞
7.3
7
*
RT274
NOMESCO Finland
NA
10.9
7.3
13
12
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
6.8
7.3
17
25
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
4.9
7.3
22
45
M54.8
ICD-10 Finland
Other dorsalgia
2.2
7.3
71
330
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
7.2
238
1636
N07AA02
ATC
pyridostigmine; systemic
6.3
7.2
18
29
M50.3
ICD-10 Finland
Other cervical disc degeneration
2.6
7.2
50
194
A06AD11
ATC
lactulose; oral
1.5
7.2
223
1509
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.7
7.2
46
171
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.9
7.2
103
559
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
4.1
7.2
26
64
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
7.2
299
2157
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.9
7.2
107
590
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
7.2
461
3595
A07EA06
ATC
budesonide; oral, local oral
2.2
7.2
68
313
E000007
ATC
NA
1.9
7.2
105
576
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.3
7.1
62
272
SPAT1325
SPAT
Vaccination
1.3
7.1
584
4731
M79.3
ICD-10 Finland
Panniculitis, unspecified
7.9
7.1
15
19
S22
ICPC
Nail symptom/complaint
1.9
7.1
97
520
K02.1
ICD-10 Finland
Caries of dentine
1.3
7.1
1029
9012
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.1
7.1
79
388
N06AB04
ATC
citalopram; systemic
1.4
7.1
397
3028
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.9
7.1
106
585
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.0
7.1
37
123
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.8
7.0
117
669
R05
ICPC
Cough
1.4
7.0
390
2965
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.7
7.0
45
167
R68.2
ICD-10 Finland
Dry mouth, unspecified
4.3
7.0
24
56
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.6
7.0
29
81
SXC03
NOMESCO Finland
Other oral or dental procedure
3.7
7.0
28
76
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
4.5
7.0
23
52
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.5
6.9
250
1753
R35
ICD-10 Finland
Polyuria
1.9
6.9
93
493
R63.4
ICD-10 Finland
Abnormal weight loss
2.4
6.9
55
232
N05CD07
ATC
temazepam; oral
1.5
6.9
208
1400
NG1DA
NOMESCO Finland
X-ray of knees
2.9
6.9
40
141
K75.4
ICD-10 Finland
Autoimmune hepatitis
13.8
6.9
11
8
R03DC03
ATC
montelukast; oral
1.4
6.9
302
2203
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.6
6.9
48
188
XG405
NOMESCO Finland
Education on PEF monitoring
3.0
6.9
36
120
J96.1
ICD-10 Finland
Chronic respiratory failure
3.2
6.9
34
109
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.8
6.8
115
659
XKD00
NOMESCO Finland
Uroflowmetry
1.6
6.8
168
1075
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
8.3
6.8
14
17
M62.9
ICD-10 Finland
Disorder of muscle, unspecified
11.0
6.8
12
11
L95.8
ICD-10 Finland
Other vasculitis limited to skin
11.0
6.8
12
11
N35.8
ICD-10 Finland
Other urethral stricture
11.0
6.8
12
11
ND2AE
NOMESCO Finland
Hand and fingers ultrasound examination
9.3
6.8
13
14
H15.1
ICD-10 Finland
Episcleritis
3.3
6.8
32
99
78880
ICD-8 Finland
Other general symptoms, Pyrexia of unknown origin
5.3
6.8
19
36
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
5.3
6.8
19
36
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
40.2
6.8
8
*
M05.2
ICD-10 Finland
Rheumatoid vasculitis
40.2
6.8
8
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.4
6.7
55
237
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.1
6.7
70
336
M02AA07
ATC
piroxicam; topical
1.3
6.7
663
5503
TQW80
NOMESCO Finland
Local dermatologic skincare
2.5
6.7
51
211
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
2.2
6.7
67
314
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
6.7
414
3206
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.0
6.7
83
427
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
2.7
6.7
43
160
L03
ICPC
Low back symptom/complaint
1.4
6.7
421
3270
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.8
6.7
107
606
WX892
NOMESCO Finland
Monitored bed care
1.8
6.7
110
625
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
6.7
197
1322
Z94.2
ICD-10 Finland
Lung transplant status
22.6
6.7
9
*
H16.0
ICD-10 Finland
Corneal ulcer
2.0
6.7
81
416
R03BB01
ATC
ipratropium bromide; inhalant
2.2
6.7
65
305
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
6.4
6.6
16
25
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
6.4
6.6
16
25
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.1
6.6
71
345
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
12.3
6.6
11
9
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
6.6
82
424
ZZA00
NOMESCO Finland
Split skin graft
2.4
6.5
50
208
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
10.0
6.5
12
12
F45.9
ICD-10 Finland
Somatoform disorder, unspecified
10.0
6.5
12
12
K92.1
ICD-10 Finland
Melaena
2.1
6.5
71
349
N03AF01
ATC
carbamazepine; oral, rectal
1.9
6.5
88
470
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
2.7
6.5
42
158
KMAK
NOMESCO Finland
NA
1.3
6.5
956
8350
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
5.0
6.5
19
38
B01AC04
ATC
clopidogrel; oral
1.5
6.5
206
1405
TQW99
NOMESCO Finland
Other minor procedure on skin
2.0
6.4
79
406
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
2.8
6.4
39
143
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
70.1
6.4
7
*
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
6.4
323
2412
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
6.4
517
4168
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
2.8
6.4
38
137
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
7.4
6.4
14
19
L93.1
ICD-10 Finland
Subacute cutaneous lupus erythematosus
14.3
6.4
10
7
RF120
NOMESCO Finland
NA
3.9
6.4
24
62
M13.8
ICD-10 Finland
Other specified arthritis
3.8
6.4
25
67
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.8
6.4
104
594
H16.9
ICD-10 Finland
Keratitis, unspecified
3.0
6.4
33
110
R06AX22
ATC
ebastine; oral
1.4
6.3
320
2394
C09CA06
ATC
candesartan; oral
1.4
6.3
373
2865
F45.0
ICD-10 Finland
Somatization disorder
5.5
6.3
17
31
GD2SN
NOMESCO Finland
Lung ventilation SPECT
5.5
6.3
17
31
RT350
NOMESCO Finland
NA
11.0
6.3
11
10
N04BC05
ATC
pramipexole; oral
1.7
6.3
124
747
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
6.3
417
3267
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
2.1
6.3
69
341
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
2.0
6.3
73
367
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
6.3
129
790
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
+∞
6.3
6
*
N08.5*M31.0
ICD-10 Finland
Glomerular disorders in Goodpasture's syndrome
+∞
6.3
6
*
J99.1*M33.9
ICD-10 Finland
Respiratory disorders in dermatopolymyositis
+∞
6.3
6
*
M31.0
ICD-10 Finland
Hypersensitivity angiitis
+∞
6.3
6
*
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.8
6.2
110
643
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.3
6.2
56
251
G03DB01
ATC
dydrogesterone; oral
1.4
6.2
276
2016
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
7.0
6.2
14
20
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
7.0
6.2
14
20
XCK00
NOMESCO Finland
Perimetry
1.7
6.2
115
682
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
1.9
6.2
89
485
D06BX01
ATC
metronidazole; topical
1.5
6.2
197
1343
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
6.2
928
8111
D07AC13
ATC
mometasone; topical
1.3
6.2
507
4097
NG4AA
NOMESCO Finland
Lower leg X-ray examination
2.3
6.2
53
233
A06AC51
ATC
ispaghula, combinations; systemic
1.8
6.2
93
517
J98.1
ICD-10 Finland
Pulmonary collapse
5.3
6.1
17
32
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.4
6.1
347
2644
J01FA01
ATC
erythromycin; systemic
1.4
6.1
256
1847
C01DA14
ATC
isosorbide mononitrate; oral
1.5
6.1
202
1389
J01DA06
ATC
[U] cefuroxime; systemic
1.4
6.1
256
1850
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
2.8
6.1
36
130
M05.3
ICD-10 Finland
Rheumatoid arthritis with involvement of other organs and systems
12.6
6.1
10
8
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.7
6.1
38
143
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
2.9
6.1
33
114
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
10.0
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
725
503
20.71
307.65
3.7
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
397
174
27.44
307.65
1.7
1.1
u/ml
67.9
50.4
—
52
5
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
865
459
29.83
307.65
3.4
1.2
g/l
1.1
1.2
15.13
841
431
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
533
334
20.55
307.65
1.7
1.1
u/ml
60.3
18.1
4.90
125
24
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
257
109
26.46
307.65
1.4
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
659
399
22.86
307.65
1.8
1.1
u/ml
19.5
3.4
6.48
249
53
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
673
438
21.42
307.65
1.8
1.1
u/ml
33.1
14.3
1.14
96
21
(3037522) Nuclear Ab [Titer] in Serum
1208
2461
9.35
307.65
2.2
1.3
titre
1104.4
390.7
30.33
660
458
(3023420) DNA double strand Ab [Units/volume] in Serum
291
175
18.93
307.65
3.1
1.1
iu/ml
35.9
25.6
—
52
5
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
254
108
26.35
307.65
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
254
108
26.35
307.65
1.4
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
655
391
23.14
307.65
1.8
1.1
u/ml
9.9
2.1
2.18
155
31
(40759836) Histone Ab [Presence] in Serum by Immunoblot
254
108
26.35
307.65
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
257
109
26.46
307.65
1.4
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
570
296
25.38
307.65
1.7
1.1
u/ml
4.2
6.2
0.17
84
18
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
257
109
26.46
307.65
1.4
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
686
657
14.53
307.65
1.7
1.2
u/ml
4.2
1.0
2.32
51
53
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
865
438
31.29
307.65
3.4
1.2
g/l
0.2
0.2
20.85
839
412
(3005719) IgG [Mass/volume] in Serum or Plasma
619
1296
6.19
295.13
3.6
2.6
g/l
11.5
10.4
4.94
587
1169
(3001604) Monocytes [#/volume] in Blood
1815
9251
5.80
280.36
12.0
5.4
e9/l
0.5
0.6
1.14
1728
7992
(3006315) Basophils [#/volume] in Blood
1819
9292
5.82
280.07
12.1
5.4
e9/l
0.0
0.0
1.28
1730
8025
(3013115) Eosinophils [#/volume] in Blood
1838
9655
5.75
267.77
12.5
5.6
e9/l
0.2
0.2
3.67
1763
8469
(3019198) Lymphocytes [#/volume] in Blood
1822
9544
5.61
265.24
12.2
5.5
e9/l
1.7
1.9
12.68
1754
8422
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
163
54
32.44
250.59
1.2
1.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
391
621
7.40
242.72
1.5
1.2
u/ml
17.1
9.8
—
10
5
(3004616) Nuclear Ab [Presence] in Serum
231
185
13.79
240.07
1.8
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1628
8424
4.30
224.42
12.4
5.6
%
0.7
0.7
1.70
1589
7833
(3013650) Neutrophils [#/volume] in Blood by Automated count
1887
10872
5.36
223.89
14.8
8.7
e9/l
3.8
4.0
3.47
1794
9494
(42870588) Differential panel, method unspecified - Blood
1342
6140
3.90
220.87
10.6
5.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
1646
8690
4.25
217.69
12.4
5.5
%
2.8
2.8
0.28
1610
8071
(3019069) Monocytes/100 leukocytes in Blood
1649
8741
4.24
216.19
12.9
5.8
%
9.0
8.4
15.23
1608
8169
(3028026) IgM [Mass/volume] in Serum or Plasma
475
1023
5.61
215.15
1.9
1.8
g/l
1.5
1.4
0.27
446
927
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
325
480
7.73
214.60
1.9
1.5
titre
566.9
277.1
0.59
26
14
(3018010) Neutrophils/100 leukocytes in Blood
1657
8892
4.20
211.38
12.1
5.4
%
58.0
56.8
3.86
1616
8310
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1204
5263
3.74
209.35
3.3
2.0
u/l
136.0
205.1
2.31
1156
4950
(3002030) Lymphocytes/100 leukocytes in Blood
1659
9014
4.12
205.21
12.6
5.6
%
27.3
28.6
6.01
1620
8387
(3038026) Centromere Ab [Units/volume] in Serum
174
113
16.59
202.82
1.7
1.1
u/ml
40.2
24.0
—
19
5
(3013293) Extractable nuclear Ab [Presence] in Serum
102
10
106.75
198.08
1.7
1.6
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
168
107
16.88
197.74
1.7
1.1
u/ml
14.9
2.3
—
36
6
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
149
94
16.89
176.02
2.0
1.2
u/l
5.7
5.7
0.01
133
80
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
868
3438
3.47
168.62
1.5
1.3
iu/ml
41.8
33.9
0.66
361
1070
(3024980) IgG subclass 4 [Mass/volume] in Serum
212
265
8.72
160.27
2.9
1.5
g/l
0.9
0.7
1.32
172
197
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
826
3289
3.38
157.29
1.4
1.2
u/ml
8.1
12.1
1.25
327
1302
(3013707) Erythrocyte sedimentation rate by Westergren method
2015
14119
4.80
139.57
10.7
3.7
mm/h
14.8
11.9
13.01
1975
13085
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1421
8128
3.00
137.44
3.0
2.2
nmol/l
80.8
77.8
3.73
1348
7342
(3028192) IgG subclass 2 [Mass/volume] in Serum
154
160
10.25
133.80
2.4
1.4
g/l
2.8
2.9
0.19
124
108
(3027135) IgG subclass 1 [Mass/volume] in Serum
154
160
10.25
133.80
2.4
1.4
g/l
7.6
6.7
0.84
122
110
(3024139) IgG subclass 3 [Mass/volume] in Serum
154
160
10.25
133.80
2.4
1.4
g/l
0.4
0.4
0.00
124
109
(4062490)
155
166
9.95
131.70
2.4
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
185
279
7.13
118.32
1.5
1.2
u/ml
4.2
4.7
0.15
95
110
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
169
234
7.72
116.68
1.7
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1989
14443
4.05
115.87
12.8
7.2
u/l
74.7
77.6
2.18
1962
13578
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
184
284
6.96
115.13
1.5
1.2
u/ml
3.8
3.7
0.03
94
84
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1468
9061
2.76
113.81
7.6
6.3
mmol/l
1.2
1.2
1.12
1293
7676
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
951
4743
2.73
113.44
3.7
2.9
ng/l
944.8
1190.5
1.69
854
3999
(3037467) Urinalysis macro (dipstick) panel - Urine
1848
12926
3.31
112.25
8.2
4.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
250
538
5.10
110.36
1.6
1.6
iu/ml
9.3
0.1
0.49
47
106
(40760892) CBC W Ordered Manual Differential panel - Blood
869
4189
2.74
110.24
8.4
4.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
85
47
18.75
106.62
2.1
1.4
ug/l
7.5
8.8
1.39
85
47
(3007164) IgA [Mass/volume] in Serum or Plasma
798
3760
2.73
104.94
1.8
1.4
g/l
2.5
2.3
1.89
572
2285
(3035350) Ketones [Presence] in Urine by Test strip
1461
9213
2.64
104.71
6.0
3.6
estimate
0.0
0.0
0.50
279
1669
(3013637) Mi-2 Ab [Presence] in Serum
72
29
25.61
102.87
1.2
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
72
29
25.61
102.87
1.2
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
72
29
25.61
102.87
1.2
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
72
29
25.61
102.87
1.2
1.0
—
—
—
0
0
(4268621)
143
189
8.01
102.61
2.4
2.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
404
1310
3.53
102.40
2.1
3.0
g/l
68.0
66.7
2.30
379
1191
(3009261) Glucose [Presence] in Urine by Test strip
1467
9350
2.61
101.45
6.1
3.6
estimate
0.0
0.0
1.32
283
1663
(3004588) Protein electrophoresis panel - Serum or Plasma
359
1083
3.75
101.43
1.8
2.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1336
8192
2.53
99.63
6.7
5.6
mmol/l
1.2
1.2
1.15
1259
7406
(3018418) pH of Serum or Plasma
997
5380
2.52
97.52
4.5
3.8
ph
7.4
7.4
1.24
166
997
(3021601) Nitrite [Presence] in Urine by Test strip
1445
9259
2.54
96.88
7.9
4.8
estimate
0.0
0.0
0.38
287
1692
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
276
751
4.05
89.91
1.7
2.0
u/l
40.4
39.4
0.32
251
664
(3017181) Myelocytes/100 leukocytes in Blood
419
1519
3.16
87.70
5.6
3.7
%
0.8
1.0
0.82
133
387
(3011397) Hemoglobin [Presence] in Urine by Test strip
840
4365
2.47
86.96
5.5
3.6
—
—
—
0
0
(3015736) pH of Urine
1178
7147
2.35
85.17
5.3
3.4
—
5.8
—
0
5
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
216
522
4.47
82.18
2.6
2.4
ug/l
193.0
813.3
0.95
200
489
(3021440) Promyelocytes/100 leukocytes in Blood
396
1447
3.10
81.36
5.7
3.8
%
0.0
0.2
5.21
124
353
(3018095) Leukocytes [#/volume] in Urine
1073
6384
2.29
79.59
5.6
3.4
e6/l
64.7
97.2
1.22
795
4369
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
455
1819
2.88
79.41
3.2
4.3
u/l
242.5
249.8
0.44
434
1721
(3025159) Blasts/100 leukocytes in Blood
371
1360
3.07
75.45
5.9
3.8
%
0.0
0.6
0.97
103
298
(3000850) Epithelial cells [#/volume] in Urine
715
3682
2.37
73.21
3.6
2.4
e6/l
4.3
7.2
7.87
654
3209
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
195
477
4.38
72.87
1.6
2.1
mg/l
10.6
11.4
0.69
180
438
(3021589) Normoblasts [#/volume] in Blood
1270
8336
2.19
71.13
15.5
8.7
e9/l
0.0
0.0
0.49
1131
6805
(3024561) Albumin [Mass/volume] in Serum or Plasma
1216
7906
2.16
69.03
5.9
4.6
g/l
35.3
35.8
2.57
1159
7376
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
213
579
3.96
68.98
1.7
2.7
g/l
11.9
10.2
3.72
195
491
(3002179) Metamyelocytes/100 leukocytes in Blood
365
1392
2.93
68.79
5.5
3.6
%
0.4
0.7
2.78
91
280
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
222
630
3.80
67.59
1.7
2.6
g/l
3.8
3.7
0.15
181
454
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
222
631
3.79
67.43
1.7
2.6
g/l
7.3
7.4
0.06
184
480
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
83
94
9.13
67.27
1.3
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
221
631
3.77
66.67
1.7
2.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
906
5323
2.17
66.00
4.6
3.0
e6/l
77.4
75.9
0.01
760
4006
(3022948) Iron [Moles/volume] in Serum or Plasma
563
2759
2.38
63.23
2.7
2.3
umol/l
12.1
13.3
3.77
530
2547
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
185
486
4.06
62.69
1.8
2.7
g/l
0.0
0.0
0.25
177
449
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
77
87
9.13
62.50
1.2
1.1
u/ml
12.3
8.3
—
7
11
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
209
600
3.73
62.45
1.8
2.7
g/l
3.1
3.1
0.17
183
465
(3034770) Mitochondria Ab [Titer] in Serum
184
483
4.06
62.42
1.3
1.2
titre
715.7
947.1
0.22
14
14
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
497
2324
2.46
61.82
2.8
2.4
%
20.8
22.7
2.64
430
1995
(40758558) Short blood count panel - Blood
835
4863
2.13
61.16
10.1
6.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
84
109
7.96
61.00
1.2
1.1
ratio
1.1
1.0
1.25
31
47
(21491868) Cryoglobulin [Mass/volume] in Serum
65
60
11.12
60.96
1.2
1.2
g/l
0.2
0.4
—
6
5
(3007566) Smooth muscle Ab [Titer] in Serum
180
482
3.97
59.35
1.3
1.2
titre
90.0
94.7
0.06
13
30
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
184
501
3.91
59.27
1.8
2.6
g/l
37.4
38.1
0.75
172
433
(3036481) Cortisol [Moles/volume] in Serum or Plasma
409
1782
2.58
58.90
2.0
2.1
nmol/l
366.8
374.9
0.23
387
1623
(36304419) Bacteria [Presence] in Urine
821
4810
2.11
58.67
4.3
2.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
582
2985
2.28
58.16
3.3
2.5
e6/l
0.8
1.2
3.08
389
1635
(3026493) Urate [Moles/volume] in Serum or Plasma
786
4542
2.12
58.15
3.0
2.4
umol/l
2990.0
5382.5
1.15
710
3935
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
193
552
3.73
57.90
1.8
2.8
g/l
0.7
0.9
0.21
179
483
(3004789) Transferrin [Mass/volume] in Serum or Plasma
512
2504
2.35
57.10
2.7
2.3
g/l
2.3
2.4
1.14
486
2317
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
83
115
7.45
56.95
1.3
1.1
titre
187.3
147.1
0.19
26
21
(3011412) CD3 cells [#/volume] in Blood
95
153
6.44
56.70
2.1
2.4
e9/l
1.1
1.1
0.02
57
92
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
793
4634
2.09
56.65
2.9
2.1
mg/l
2.9
3.0
0.15
706
3951
(3030467) Casts [#/volume] in Urine by Automated count
826
4901
2.08
56.63
4.5
2.9
e6/l
0.2
0.4
6.04
679
3643
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
169
453
3.95
55.59
1.9
2.8
g/l
0.0
0.0
0.00
161
418
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
168
449
3.96
55.49
1.9
2.8
g/l
0.0
0.0
0.00
161
418
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
319
1291
2.71
52.97
2.3
2.4
au/ml
36.9
24.0
0.63
18
82
(40761535) Cells panel - Urine sediment
348
1472
2.61
52.89
5.5
3.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
175
500
3.71
52.49
3.0
2.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
325
1336
2.67
52.29
3.4
2.9
ng/l
150.2
180.4
0.76
307
1203
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
298
1177
2.76
51.83
1.3
1.3
au/ml
25.7
43.0
1.41
11
56
(3042936) Bacteria identified in Isolate by Culture
491
2481
2.25
49.98
2.7
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
750
4483
2.00
48.87
5.6
4.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
426
2051
2.33
48.52
1.6
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
144
394
3.83
45.91
1.8
1.7
e6/l
10096.7
11516.8
0.18
112
291
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1321
9654
1.88
45.75
7.1
6.1
umol/l
9.7
10.7
5.18
1276
9148
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
69
104
6.81
43.84
2.0
2.4
e6/l
429.2
528.5
0.47
58
83
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
123
314
4.08
43.17
6.5
5.3
iu/ml
297.8
359.2
0.09
13
41
(3027945) Reticulocytes/100 erythrocytes in Blood
380
1825
2.30
43.14
3.7
2.6
%
1.7
1.8
1.95
358
1623
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
66
98
6.91
42.51
2.0
2.5
e9/l
0.2
0.2
0.35
58
82
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1200
8635
1.83
42.34
3.6
2.8
ug/l
113.2
102.2
1.03
1135
8042
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
199
705
3.00
42.04
2.3
1.8
g/l
1.4
1.5
0.79
182
614
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
72
119
6.22
41.86
2.0
2.1
%
12.5
13.1
0.13
33
48
(3031040) Bacteria [#/volume] in Urine by Automated count
1587
12480
1.90
41.72
6.4
4.4
e6/l
3933.1
2343.7
0.35
31
159
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
149
445
3.51
41.70
1.5
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
413
2093
2.19
40.98
2.2
1.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
49
54
9.25
40.46
1.3
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
775
4944
1.86
39.84
7.1
3.9
estimate
0.0
0.0
0.19
288
1669
(3019150) Specific gravity of Urine by Refractometry
665
4041
1.91
39.76
6.5
4.0
kg/l
1.0
1.0
1.88
88
591
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1024
7120
1.80
39.60
6.5
3.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
213
810
2.80
39.46
1.3
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
124
342
3.78
39.04
1.3
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
504
2800
2.03
39.03
2.3
1.8
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
74
137
5.55
38.27
2.3
2.1
%
54.2
42.1
1.70
13
17
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
48
56
8.73
37.93
1.1
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
66
111
6.09
37.71
2.2
2.6
e6/l
587.7
687.6
0.47
30
45
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
68
118
5.91
37.64
2.0
2.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
123
347
3.69
37.47
3.9
3.5
%
59.7
57.7
0.96
123
347
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
101
250
4.18
36.93
2.8
3.0
u/ml
402.3
1864.1
—
6
15
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1051
7468
1.76
36.87
2.1
1.9
pmol/l
99.0
96.9
0.71
552
3753
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
703
4438
1.85
36.78
1.4
1.3
u/ml
2.1
1.5
0.47
185
1186
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
126
366
3.59
36.75
1.3
1.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
150
495
3.17
35.72
1.9
4.0
mg/l
36.1
53.5
0.71
123
408
(3021960) Folate [Moles/volume] in Serum or Plasma
664
4160
1.84
35.36
1.6
1.5
nmol/l
20.0
21.2
1.53
588
3567
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
957
6678
1.75
35.32
4.4
3.4
ng/l
27.2
40.1
1.23
654
4219
(3021879) Hepatitis B virus core Ab [Presence] in Serum
289
1340
2.33
35.21
1.4
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
149
494
3.16
35.20
2.0
4.0
mg/l
46.5
66.8
0.68
123
405
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
67
123
5.58
34.96
2.0
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
406
2181
2.05
34.05
1.9
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
144
480
3.14
33.70
2.0
4.0
ratio
1.3
1.8
0.55
13
39
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2121
18998
2.77
33.63
27.0
12.8
mg/l
18.0
22.0
10.70
1881
14876
(3003458) Phosphate [Moles/volume] in Serum or Plasma
411
2230
2.03
33.49
5.8
5.3
mmol/l
1.0
1.0
0.31
389
2066
(3015377) Calcium [Moles/volume] in Serum or Plasma
927
6483
1.73
33.42
3.5
3.4
mmol/l
2.3
2.4
2.61
824
5727
(3029075) Extractable nuclear Ab panel - Serum
41
46
9.06
33.38
1.1
1.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
168
616
2.87
33.22
2.5
2.0
ug/l
1.7
2.1
0.24
146
534
(46235355) HIV 1 and 2 tests - Meaningful Use set
548
3305
1.87
32.54
1.7
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
484
2804
1.92
32.53
1.6
1.6
—
—
—
0
0
(3034426) Prothrombin time (PT)
46
63
7.43
31.84
1.3
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
965
6923
1.69
30.97
10.8
8.0
inr
1.2
1.2
0.21
269
2038
(3012095) Magnesium [Moles/volume] in Serum or Plasma
483
2851
1.88
30.44
4.2
3.3
mmol/l
0.8
0.8
0.53
457
2661
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
327
1687
2.10
30.35
2.8
2.2
g/l
0.2
0.2
0.07
304
1581
(3023520) Reticulocytes [#/volume] in Blood
278
1351
2.21
30.06
2.7
2.6
e9/l
68.0
71.7
0.99
205
1022
(3004809) Band form neutrophils/100 leukocytes in Blood
93
254
3.77
29.69
2.5
3.4
%
1.5
1.5
0.01
76
203
(3021788) Differential panel - Synovial fluid
101
294
3.55
29.35
1.4
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
656
4305
1.74
28.79
2.0
1.8
mg/l
1.1
1.1
0.07
516
3270
(3019309) Folate [Moles/volume] in Red Blood Cells
521
3202
1.81
28.63
1.8
1.7
nmol/l
1224.4
1184.9
0.46
435
2407
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
355
1926
2.00
28.59
2.1
1.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
264
1286
2.19
28.31
1.4
1.3
u/ml
213.4
185.6
0.22
240
1176
(3013826) Glucose [Moles/volume] in Serum or Plasma
1337
10611
1.63
27.56
5.9
4.4
mmol/l
6.4
6.6
4.58
1276
9886
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
867
6202
1.64
27.12
4.3
3.1
u/l
32.6
32.9
0.07
835
5898
(3026782) Osmolality of Urine
542
3422
1.77
26.99
4.0
2.6
mosm/kgh2o
509.4
534.6
2.11
478
2910
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
104
327
3.28
26.80
1.8
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
461
2783
1.82
26.66
3.8
2.6
e6/l
2.1
3.4
3.46
271
1443
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
817
5779
1.65
26.59
2.9
2.5
u/l
62.0
56.7
1.09
775
5331
(3048689) Calprotectin [Mass/mass] in Stool
410
2410
1.86
25.76
2.2
2.2
ug/g
121.8
119.3
0.04
325
1895
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
348
1940
1.94
25.73
2.2
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
821
5878
1.62
25.09
3.7
3.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
107
358
3.09
24.87
2.0
4.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
267
1373
2.07
24.75
8.0
7.2
mmol/l
8.9
9.0
0.12
251
1313
(3045414) Leukocytes [Presence] in Urine
194
888
2.30
24.09
2.1
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
99
326
3.13
23.65
1.4
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
32
41
7.90
23.42
1.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
58
135
4.38
23.00
1.2
1.2
titre
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
99
333
3.06
22.81
1.4
1.3
—
17.4
—
0
9
(3006184) Hemoglobin [Mass/volume] in Capillary blood
101
348
2.99
22.32
2.3
2.2
g/l
125.5
129.7
0.77
59
255
(36660697) Celiac disease serology panel - Serum
287
1569
1.95
22.31
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
97
327
3.05
22.27
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
428
2655
1.75
22.17
1.3
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
91
298
3.14
21.95
1.3
1.3
u/ml
135.5
113.9
0.36
15
57
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
179
824
2.27
21.90
1.1
1.1
u/ml
1.8
0.9
—
7
8
(3018677) aPTT in Platelet poor plasma by Coagulation assay
424
2633
1.75
21.85
2.4
2.1
s
29.8
29.4
0.76
415
2558
(3003396) Base excess in Arterial blood by calculation
331
1912
1.86
21.71
7.9
7.4
mmol/l
1.2
1.1
0.10
266
1492
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
49
105
4.75
21.52
2.4
2.8
%
44.8
43.5
0.16
16
32
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
515
3386
1.67
21.49
4.7
3.5
ng/l
273.2
319.1
0.25
390
2454
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
91
302
3.10
21.47
1.3
1.2
u/ml
304.8
274.2
0.22
59
186
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
331
1919
1.85
21.45
8.0
7.4
kpa
5.0
5.1
0.75
313
1835
(3022217) INR in Platelet poor plasma by Coagulation assay
356
2114
1.81
21.33
24.0
23.1
inr
1.3
1.3
0.01
71
292
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
243
1275
2.01
21.21
1.8
1.7
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
330
1919
1.84
21.16
8.0
7.4
kpa
12.2
12.8
1.21
312
1835
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
32
48
6.75
20.42
2.3
2.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
249
1335
1.97
20.42
3.5
2.9
e9/l
3.7
4.0
1.22
194
1079
(3030981) Hyaline casts [#/volume] in Urine by Automated count
178
842
2.21
20.38
3.5
2.6
e6/l
0.1
0.3
2.02
171
808
(3016502) Oxygen saturation in Arterial blood
295
1681
1.87
20.12
8.5
7.9
%
95.5
95.9
0.64
281
1624
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
51
120
4.32
19.97
1.2
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
199
994
2.10
19.82
4.9
3.4
kpa
5.2
5.2
0.14
190
929
(3048929) Epstein Barr virus Ab [Presence] in Serum
128
532
2.49
19.70
1.3
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
37
67
5.60
19.62
2.2
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
71
214
3.39
19.61
3.1
2.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1756
15425
1.61
19.43
4.9
4.3
pmol/l
14.8
14.7
1.83
1667
14188
(3023419) Bacteria identified in Sputum by Culture
69
207
3.41
19.20
3.1
2.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
64
183
3.57
19.16
2.7
3.9
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
58
155
3.81
19.16
2.3
3.1
%
59.4
57.5
0.22
36
107
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
261
1453
1.90
19.10
3.0
2.4
ml/min/173m2
64.7
68.0
0.69
115
578
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
72
225
3.27
18.79
1.8
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
514
3481
1.62
18.75
2.7
3.0
mmol/l
2.4
2.5
0.33
460
3079
(3009343) pH of Capillary blood
193
983
2.05
18.23
4.9
3.4
ph
7.4
7.4
1.54
30
121
(3044927) Protein electrophoresis panel - Urine
55
147
3.81
18.17
1.1
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
193
986
2.05
18.07
1.7
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
686
5001
1.53
18.03
5.6
3.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
105
415
2.60
17.95
1.9
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
54
144
3.82
17.90
1.8
1.5
%
32.0
37.8
0.54
33
90
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
124
533
2.40
17.75
2.6
2.5
%
174.6
182.8
0.47
116
510
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
186
947
2.05
17.58
4.8
3.4
mmol/l
1.9
1.9
0.01
145
711
(3044941) Cell count panel - Synovial fluid
77
261
3.02
17.55
1.5
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
84
300
2.87
17.45
1.7
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1016
8065
1.47
17.44
2.3
2.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
247
1391
1.87
17.39
2.5
2.3
ug/l
11.0
6.5
0.68
210
1215
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
252
1430
1.86
17.32
3.5
3.5
ng/l
80.3
80.2
0.01
232
1229
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
32
57
5.68
17.28
1.1
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
63
191
3.36
17.27
1.7
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
125
546
2.36
17.26
1.1
1.1
u/ml
6.6
4.4
0.32
14
73
(3008898) HLA-B27 [Presence]
150
708
2.20
17.25
1.1
1.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
345
2151
1.71
17.21
2.9
2.5
umol/l
6.3
7.5
1.00
301
1858
(3022621) pH of Urine by Test strip
226
1241
1.91
17.19
3.4
2.9
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
95
365
2.67
17.19
4.7
2.9
mmol/l
24.6
25.2
0.59
86
322
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1962
17891
1.71
16.88
6.0
5.0
mu/l
1.9
2.0
0.65
1873
16536
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
127
566
2.32
16.76
2.4
2.2
%
98.1
91.7
2.52
119
525
(3000093) Morphology [Interpretation] in Blood Narrative
50
134
3.79
16.48
1.1
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
61
187
3.32
16.44
1.7
1.6
%
54.0
59.7
0.46
32
117
(3037692) Legionella sp identified in Specimen by Organism specific culture
30
53
5.72
16.34
1.7
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
74
259
2.92
15.96
4.1
2.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
118
521
2.33
15.91
1.4
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
81
299
2.77
15.85
2.0
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
638
4685
1.50
15.82
5.3
3.7
%
93.7
93.5
0.06
620
4567
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
25
38
6.64
15.75
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
297
1821
1.73
15.66
4.2
4.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
58
178
3.32
15.62
1.7
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
62
200
3.16
15.40
1.2
1.2
u/l
44.2
53.1
1.05
51
141
(3036489) Thrombin time
141
683
2.13
15.20
2.4
2.1
s
22.3
20.9
1.08
121
599
(3002173) Hemoglobin [Mass/volume] in Arterial blood
264
1581
1.76
15.11
9.1
8.3
g/l
119.0
120.4
0.56
251
1523
(3014111) Lactate [Moles/volume] in Serum or Plasma
250
1476
1.78
15.03
7.4
6.6
mmol/l
1.2
1.3
0.92
243
1428
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
35
78
4.54
14.71
2.4
3.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
97
410
2.43
14.44
1.9
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
83
326
2.60
14.41
1.6
1.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
29
56
5.23
14.38
2.2
2.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
84
333
2.58
14.32
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
117
542
2.22
14.11
1.3
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
327
2117
1.64
13.96
8.7
6.5
mmol/l
104.4
104.4
0.01
315
2073
(3014051) Protein [Presence] in Urine by Test strip
104
462
2.31
13.86
2.4
2.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
233
1381
1.77
13.79
8.5
8.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
51
159
3.26
13.43
1.5
1.4
e6/l
4639.4
100561.5
1.24
38
118
(3021447) Carbon dioxide [Partial pressure] in Venous blood
245
1488
1.72
13.30
3.6
3.5
kpa
5.9
5.8
0.72
237
1451
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
80
322
2.54
13.24
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
73
281
2.65
13.22
1.4
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
141
720
2.02
13.22
2.4
1.9
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
20
29
6.95
13.14
1.4
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
242
1471
1.72
13.09
3.7
3.5
mmol/l
2.4
2.0
1.10
207
1205
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
103
469
2.25
12.96
1.9
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
141
730
1.99
12.72
4.6
3.5
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
41
115
3.61
12.71
1.2
1.1
nmol/l
0.4
6.2
0.64
11
21
(44806071)
18
24
7.55
12.70
1.1
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
162
881
1.90
12.66
9.6
9.2
mmol/l
24.1
24.4
0.62
148
832
(3013512) EKG study
674
5183
1.43
12.63
4.5
3.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
109
518
2.16
12.37
1.1
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
177
999
1.84
12.32
1.6
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
49
158
3.15
12.24
1.6
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
49
158
3.15
12.24
1.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
49
158
3.15
12.24
1.6
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
62
229
2.76
12.18
2.1
1.5
—
—
—
0
0
(4010399)
218
1315
1.73
12.11
1.7
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
127
649
2.01
11.90
2.2
1.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
27
58
4.70
11.89
4.7
4.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
185
1070
1.79
11.88
5.4
5.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
60
221
2.76
11.86
1.6
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
69
273
2.58
11.86
1.4
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
32
79
4.09
11.85
1.6
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
32
79
4.09
11.85
1.6
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
180
1035
1.80
11.79
7.7
7.1
mmol/l
25.2
24.5
1.28
168
960
(3044889) 12 lead EKG panel
1488
13144
1.38
11.68
4.8
3.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
50
169
3.00
11.55
1.4
2.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
22
41
5.41
11.35
2.0
2.1
e6/l
130.7
143.3
0.08
14
18
(3017704) Immunofixation for Urine
33
87
3.83
11.20
1.3
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
238
1507
1.65
11.01
1.3
1.2
iu/ml
150.5
150.1
0.01
80
579
(3042733) HLA Ab [Presence] in Serum
20
35
5.76
11.01
7.3
4.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1751
15960
1.42
10.99
29.4
15.8
%
13.9
13.7
10.65
1738
15621
(3028433) Virus identified in Specimen by Culture
25
54
4.67
10.94
1.2
1.3
—
—
—
0
0
(3000492) Spirometry study
276
1817
1.59
10.89
1.8
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
21
39
5.43
10.87
1.3
1.1
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
24
51
4.75
10.71
1.6
1.4
%
44.5
43.0
0.06
19
44
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
68
285
2.43
10.39
1.1
1.0
u/ml
3.4
2.2
0.46
19
134
(4306422)
68
286
2.42
10.32
1.2
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2123
20217
1.77
10.28
20.2
10.0
u/l
24.5
24.9
0.76
2104
19551
(4035726)
260
1712
1.59
10.23
1.5
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
41
133
3.12
10.19
1.0
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1050
8901
1.33
10.13
4.9
3.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2053
19402
1.61
9.97
23.6
14.6
mmol/l
139.4
139.7
6.43
2022
18915
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
99
494
2.05
9.94
1.4
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
63
261
2.45
9.89
1.7
1.4
—
—
—
0
0
(4027681)
36
110
3.31
9.86
1.3
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
109
566
1.97
9.80
1.3
1.4
ug/g
315.6
300.7
0.32
58
309
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
68
293
2.36
9.80
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
323
2253
1.51
9.78
8.4
6.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
545
6917
0.72
9.78
2.8
2.7
—
—
—
0
0
(3019174) dRVVT (LA screen)
15
22
6.86
9.73
1.3
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
68
295
2.35
9.65
1.0
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
138
779
1.82
9.63
3.6
3.9
mmol/l
24.7
24.2
1.20
130
708
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
41
139
2.99
9.47
1.2
1.2
mg/l
35.7
38.9
0.25
35
116
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
97
491
2.02
9.38
4.1
3.6
u/ml
0.3
0.4
0.33
56
277
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
85
410
2.11
9.35
1.2
1.3
mmol/l
3.7
3.7
0.18
77
389
(21494434) Karyotype in Bone marrow
43
151
2.88
9.34
1.1
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
33
99
3.37
9.31
1.1
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
22
49
4.52
9.30
1.9
2.5
au/ml
143.5
38.8
—
5
6
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
46
168
2.77
9.30
3.1
3.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
14
20
7.04
9.29
1.4
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2054
19463
1.58
9.27
23.8
14.7
mmol/l
3.9
3.9
1.75
2020
18942
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
32
95
3.40
9.18
1.5
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
32
95
3.40
9.18
1.5
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
32
95
3.40
9.18
1.5
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
32
95
3.40
9.18
1.5
1.5
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
39
131
3.01
9.16
1.1
1.1
mg/l
226.4
243.9
0.27
33
115
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
507
3891
1.39
9.15
1.7
1.7
pmol/l
461.3
34516166.4
3.73
442
3242
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
47
176
2.71
9.07
1.0
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
84
409
2.09
9.03
1.4
1.5
e6/l
269.1
1417.5
0.95
72
328
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
47
177
2.69
8.98
2.4
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
27
73
3.73
8.89
1.3
1.2
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
47
178
2.68
8.89
1.3
1.3
g/l
32.3
33.7
0.27
39
156
(3000330) Specific gravity of Urine by Test strip
155
932
1.71
8.72
4.1
3.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
38
130
2.96
8.66
1.4
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
83
409
2.07
8.66
1.3
1.4
e6/l
8.5
22.4
0.91
67
308
(3024263) Appearance of Synovial fluid
29
84
3.48
8.65
1.8
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1913
17917
1.43
8.63
20.5
11.9
ml/min/173m2
83.5
82.4
1.59
1710
14748
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
162
989
1.69
8.62
7.4
6.7
mmol/l
25.0
25.0
0.01
162
984
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
26
70
3.75
8.61
1.0
1.1
iu/ml
301.3
187.7
0.35
26
70
(3003181) Sodium [Moles/volume] in Urine
68
312
2.22
8.51
1.4
1.3
mmol/l
57.2
61.5
0.40
58
257
(3024354) Oxygen [Partial pressure] in Venous blood
192
1232
1.61
8.41
3.2
2.8
kpa
4.8
4.6
0.28
185
1198
(3023199) Leukocytes [#/volume] in Pleural fluid
44
166
2.68
8.40
1.3
1.3
e6/l
4780.3
2578.9
0.50
25
112
(3014007) Fractional oxyhemoglobin in Arterial blood
168
1051
1.65
8.15
10.5
8.7
%
93.8
94.1
0.26
168
1046
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
570
4534
1.34
8.07
2.8
2.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
100
541
1.89
8.02
3.2
3.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
38
136
2.82
8.02
1.3
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
478
3704
1.37
8.01
1.6
1.5
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
25
69
3.65
8.01
1.3
1.1
g/l
0.3
0.3
0.26
17
56
(3016650) Hepatitis A virus Ab [Presence] in Serum
64
294
2.21
8.00
1.1
1.1
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
12
17
7.09
7.99
1.3
1.4
mmol/l
5.0
6.1
—
6
12
(3023183) Ammonium ion [Moles/volume] in Plasma
70
334
2.13
7.97
2.2
3.2
umol/l
30.2
36.1
1.45
65
289
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
36
126
2.89
7.91
1.8
1.6
u/l
10.1
6.2
0.23
21
60
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
54
232
2.36
7.89
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
145
883
1.69
7.81
12.3
10.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
21
52
4.07
7.80
2.5
2.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
219
1475
1.54
7.78
4.2
3.5
mmol/l
1.2
1.2
0.27
206
1276
(3028308) Erythrocytes [#/volume] in Pleural fluid
39
145
2.72
7.68
1.2
1.3
e6/l
116926.9
111693.6
0.02
16
78
(40768446) Kidney Pathology biopsy report
21
53
3.99
7.61
1.5
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
64
302
2.15
7.51
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
48
201
2.42
7.44
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
58
265
2.22
7.37
1.2
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
80
416
1.96
7.24
1.3
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
252
1775
1.47
7.22
2.4
2.3
u/l
38.9
37.3
0.09
217
1508
(3045424) Erythrocytes [Presence] in Urine
66
321
2.09
7.18
1.7
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
110
636
1.77
7.15
1.8
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1394
12603
1.27
7.10
3.4
3.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
19
47
4.07
7.08
1.4
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
94
521
1.84
7.03
6.4
7.5
mmol/l
1.4
1.3
0.65
84
453
(3037121) Protein [Mass/volume] in Urine
105
603
1.78
6.99
2.3
3.3
g/l
0.4
0.3
0.41
34
228
(44790049)
47
202
2.35
6.90
2.1
1.3
—
—
—
0
0
(44790047)
47
202
2.35
6.90
2.1
1.3
—
—
—
0
0
(44806118)
47
202
2.35
6.90
2.1
1.3
—
—
—
0
0
(44790048)
47
202
2.35
6.90
2.1
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
48
209
2.32
6.85
1.3
1.7
—
1744.0
—
0
5
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
35
131
2.70
6.84
1.5
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
292
2140
1.42
6.76
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
151
965
1.60
6.76
2.3
2.4
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
10
6
16.73
6.74
1.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
42
174
2.44
6.69
1.3
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
713
5989
1.28
6.53
2.9
2.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
172
1146
1.54
6.44
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
46
203
2.29
6.39
1.7
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1385
12592
1.26
6.35
4.0
3.0
u/l
55.1
44.5
2.30
1312
11770
(40767503) Oxygen content in Capillary blood by calculation
64
325
2.00
6.24
3.5
2.4
%
16.0
16.3
0.27
40
157
(3008536) Aspergillus sp Ab [Presence] in Serum
13
26
5.02
6.22
1.5
2.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
11
19
5.81
6.11
2.7
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
194
1343
1.49
6.07
2.9
3.3
pmol/l
4.3
4.5
1.48
179
1194
(3024471) HLA-A [Type]
17
44
3.89
5.98
1.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
17
44
3.89
5.98
1.1
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
14
31
4.54
5.98
2.0
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
35
141
2.51
5.95
1.2
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
24
79
3.06
5.92
1.5
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
24
79
3.06
5.92
1.5
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
24
79
3.06
5.92
1.5
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
100
597
1.71
5.86
1.2
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
29
107
2.73
5.86
1.1
1.1
u/l
1.4
1.1
0.48
15
60
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
30
113
2.68
5.83
1.4
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
38
161
2.38
5.81
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
58
293
2.01
5.77
1.1
1.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
23
75
3.09
5.77
1.7
1.3
%
2.3
4.6
—
7
15
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
106
647
1.67
5.73
5.2
3.6
mmol/l
24.7
25.0
0.37
98
600
(3001964) Herpes simplex virus Ag [Presence] in Specimen
19
55
3.48
5.73
2.1
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
20
60
3.35
5.72
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
101
609
1.69
5.72
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
47
220
2.16
5.71
1.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
43
195
2.23
5.64
2.4
2.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
36
151
2.41
5.63
1.1
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
41
183
2.26
5.59
1.2
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
12
25
4.82
5.49
1.0
3.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
99
601
1.68
5.48
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
26
94
2.79
5.47
1.0
1.1
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
19
58
3.29
5.30
35.5
29.3
ug/l
7.0
7.2
0.16
19
49
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
31
125
2.50
5.29
1.1
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
63
340
1.88
5.20
5.2
3.6
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
26
97
2.70
5.17
1.7
2.2
%
99.7
102.0
0.12
26
92
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
103
2.64
5.15
2.0
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
44
211
2.11
5.06
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
130
863
1.54
5.00
1.5
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
67
374
1.82
4.99
1.3
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
46
3.50
4.89
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
27
106
2.57
4.88
1.1
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
24
89
2.71
4.84
2.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
66
371
1.80
4.82
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
66
371
1.80
4.82
1.5
1.3
—
—
—
0
0
(3020891) Body temperature
104
662
1.60
4.81
4.8
4.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
8
7
11.46
4.78
1.1
1.0
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
19
64
2.99
4.55
1.0
1.1
%
94.2
91.3
0.15
14
35
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
19
64
2.99
4.55
1.1
1.2
%
101.3
114.9
1.07
19
59
(3009508) Creatinine [Moles/volume] in Urine
639
5494
1.23
4.46
3.4
3.1
mmol/l
6.7
7.1
1.56
553
4646
(3012516) Albumin [Mass/volume] in Urine
598
5108
1.23
4.44
3.5
3.2
mg/l
741.5
351.3
0.77
387
3092
(21494755) Public health laboratory ask at order entry panel
130
1862
0.68
4.40
1.3
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
34
156
2.20
4.40
1.3
1.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
102
662
1.57
4.38
6.3
6.2
%
1.6
1.6
0.53
96
619
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
9
12
7.52
4.35
1.2
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
125
1798
0.68
4.33
1.8
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
23
89
2.60
4.30
2.1
1.4
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
17
56
3.05
4.24
1.4
1.2
g/l
37.3
38.1
—
7
30
(3027273) Bicarbonate [Moles/volume] in Venous blood
113
758
1.52
4.19
3.7
2.9
mmol/l
25.9
25.4
0.61
108
738
(3024891) Influenza virus A+B Ag [Presence] in Specimen
81
504
1.63
4.15
1.2
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
22
85
2.60
4.14
2.2
3.3
ph
7.5
7.4
1.16
13
26
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
18
63
2.87
4.06
1.0
1.4
%
95.6
94.9
0.03
13
35
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
99
2.44
3.97
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
14
43
3.27
3.90
1.0
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
28
125
2.26
3.90
2.0
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
100
665
1.53
3.89
6.4
6.3
%
0.9
0.9
0.35
93
621
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
10
24
4.18
3.89
1.1
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
10
24
4.18
3.89
1.0
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
84
539
1.58
3.82
1.5
1.9
iu/l
116.1
4.5
0.49
28
196
(3016018) Differential panel - Cerebral spinal fluid
37
187
1.99
3.78
1.1
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
80
509
1.59
3.78
4.7
3.5
mmol/l
3.9
3.8
0.30
75
479
(3019768) Coxiella burnetii Ab [Presence] in Serum
7
8
8.77
3.77
1.0
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
45
245
1.85
3.71
1.4
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
15
50
3.01
3.69
1.2
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
8
12
6.68
3.67
1.1
1.0
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
8
12
6.68
3.67
1.0
1.2
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
23
97
2.39
3.65
1.1
1.2
u/l
95.7
77.6
0.66
18
77
(3027456) Digoxin [Moles/volume] in Serum or Plasma
56
328
1.73
3.64
3.1
3.1
nmol/l
0.7
0.8
0.99
45
255
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1804
17258
1.22
3.59
5.8
5.5
mmol/mol
38.6
39.3
3.49
1719
16002
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
44
241
1.84
3.57
1.3
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
81
1218
0.65
3.54
1.6
1.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
17
5.31
3.51
1.1
1.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
13
6.17
3.50
1.5
1.1
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
8
13
6.17
3.50
1.5
1.2
umol/l
85.8
79.2
—
8
13
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
34
172
1.99
3.49
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
34
172
1.99
3.49
1.4
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
31
3.56
3.48
1.1
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
44
244
1.82
3.45
1.4
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
614
5376
1.19
3.42
4.3
3.8
mg/mmol
15.0
8.5
1.45
401
3274
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
14
47
2.99
3.41
1.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
30
147
2.05
3.36
1.1
1.5
umol/l
12.9
11.7
0.45
30
138
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
28
134
2.10
3.34
1.9
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
43
240
1.81
3.31
1.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
43
240
1.81
3.31
1.4
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
17
65
2.63
3.30
1.5
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
43
242
1.79
3.23
1.4
1.5
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
23
103
2.25
3.22
1.1
1.7
ug/l
9.4
8.2
0.12
18
89
(40765096) Chromosome analysis panel by Banding
14
49
2.87
3.19
1.3
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
8
15
5.35
3.19
1.1
1.9
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
7
11
6.38
3.18
1.1
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
12
39
3.09
3.09
1.2
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
8
7.52
3.05
1.2
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
108
769
1.42
3.05
1.6
1.7
—
—
—
0
0
(3035880) pH of Pleural fluid
18
74
2.44
3.04
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
31
160
1.95
3.04
1.2
1.8
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
40
225
1.79
3.03
2.5
2.2
mg/l
33.5
26.0
—
8
61
(3039000) Anion gap in Blood
59
370
1.61
3.02
7.7
9.1
mmol/l
10.4
11.2
1.03
53
332
(3018572) Chloride [Moles/volume] in Blood
59
371
1.61
2.99
7.7
9.1
mmol/l
104.4
105.0
0.30
53
333
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
19
81
2.36
2.98
1.1
1.1
miu/ml
1333.5
1627.3
0.67
19
81
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
14
51
2.76
2.98
1.1
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
51
2.76
2.98
1.1
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
21
94
2.25
2.96
1.3
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
143
1076
1.35
2.92
1.5
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
21
95
2.22
2.90
1.3
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
18
76
2.38
2.89
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
18
76
2.38
2.89
1.3
1.4
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
14
52
2.70
2.89
1.4
2.2
mg/l
8.6
10.3
0.44
14
42
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
9
22
4.10
2.88
1.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
9
22
4.10
2.88
1.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
17
70
2.44
2.88
1.4
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
77
520
1.50
2.87
1.2
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
35
193
1.83
2.84
3.1
3.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
19
83
2.30
2.84
1.1
2.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1701
16290
1.18
2.84
32.5
16.7
g/l
329.8
331.7
13.71
1693
16176
(3009214) Lutropin [Units/volume] in Serum or Plasma
67
442
1.53
2.79
1.3
1.4
u/l
11.9
12.2
0.06
61
356
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
10
31
3.24
2.77
1.0
1.2
ug/l
478.5
45.7
—
5
15
(3025018) Bordetella pertussis Ab [Titer] in Serum
24
118
2.04
2.71
1.3
1.2
—
—
—
0
0
(4211845)
20
93
2.16
2.61
4.5
2.9
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
18
80
2.26
2.60
1.4
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
18
80
2.26
2.60
1.8
2.1
ug/l
17.3
19.0
0.19
18
68
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
25
3.61
2.57
1.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
15
62
2.43
2.54
1.2
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
10
33
3.04
2.52
1.9
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
475
4168
1.18
2.52
1.5
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
52
333
1.57
2.49
1.1
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
11
39
2.83
2.47
1.0
1.5
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
8
21
3.82
2.46
1.1
1.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
25
130
1.93
2.45
1.0
1.5
—
24.7
—
0
24
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
54
352
1.55
2.41
3.4
2.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
10
34
2.95
2.41
1.2
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
10
34
2.95
2.41
2.3
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
62
901
0.68
2.38
1.4
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
33
190
1.75
2.37
1.3
1.6
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
8
6.26
2.37
1.0
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2034
19865
1.23
2.37
20.8
12.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
38
228
1.68
2.37
3.3
2.0
u/ml
11.4
21.9
0.26
38
216
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
26
139
1.88
2.36
1.1
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
22
3.65
2.36
1.3
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
46
2.62
2.36
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
46
2.62
2.36
1.1
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
33
191
1.74
2.34
1.8
1.4
mosm/kgh2o
276.6
277.6
0.09
28
146
(3012501) Base excess in Blood by calculation
55
363
1.53
2.33
6.2
3.9
mmol/l
2.7
2.7
0.01
40
248
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
28
3.22
2.30
5.2
2.5
—
—
—
0
0
(4212803)
6
13
4.62
2.27
1.0
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
13
4.62
2.27
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
194
1579
1.25
2.25
7.4
3.9
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
8
24
3.34
2.18
1.0
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
251
2110
1.21
2.16
1.5
1.7
%
1.5
1.4
0.34
222
1860
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
6
14
4.29
2.15
1.2
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
5
10
5.01
2.07
1.2
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
42
270
1.57
2.03
1.3
1.2
u/l
74.6
23.9
0.63
36
231
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
218
1821
1.22
2.01
4.1
3.1
—
—
—
0
0
(4015189)
11
44
2.51
2.01
3.2
2.8
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
8
27
2.97
1.93
1.1
3.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
17
85
2.01
1.90
5.1
3.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
22
3.19
1.88
3.0
2.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
49
333
1.48
1.87
1.6
1.4
u/l
14.1
27.1
4.19
44
277
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
28
2.86
1.86
1.1
1.2
ng/l
71.1
87.5
—
8
28
(3017569) Oxygen content in Arterial blood
16
79
2.03
1.85
4.4
2.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
40
2.51
1.83
1.0
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
50
343
1.47
1.83
1.5
1.4
nmol/l
0.3
0.3
0.03
41
258
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
20
108
1.86
1.81
1.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
21
116
1.82
1.78
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
13
60
2.17
1.77
3.3
2.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
20
109
1.84
1.77
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
34
216
1.58
1.76
1.5
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
94
723
1.31
1.76
2.0
2.1
nmol/l
11.3
11.6
0.11
82
642
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
6
18
3.34
1.74
1.2
1.1
u/l
19.8
27.9
—
6
12
(3010421) pH of Blood
62
448
1.39
1.73
5.7
3.6
ph
7.4
7.4
0.01
55
359
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1887
18406
1.15
1.72
4.6
4.4
mmol/l
5.7
5.9
5.24
1771
16860
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
24
2.92
1.72
1.0
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
2144
21141
1.25
1.71
37.4
19.2
fl
91.5
90.9
5.57
2133
20866
(3007461) Platelets [#/volume] in Blood
2143
21132
1.25
1.69
37.6
19.3
e9/l
260.5
258.5
0.70
2119
20631
(3035941) MCH [Entitic mass]
2144
21144
1.25
1.68
37.3
19.2
pg
30.2
30.2
0.04
2133
20866
(3026361) Erythrocytes [#/volume] in Blood
2144
21145
1.25
1.67
37.5
19.3
e12/l
4.4
4.5
13.90
2115
20590
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
18
318
0.56
1.67
1.3
1.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
26
157
1.66
1.65
1.3
1.1
nmol/l
337.2
395.2
0.75
18
144
(3010813) Leukocytes [#/volume] in Blood
2144
21148
1.25
1.65
37.6
19.3
e9/l
6.5
6.6
1.34
2115
20584
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
25
2.81
1.65
1.4
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
11
226
0.48
1.65
1.1
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2144
21152
1.24
1.62
37.8
19.4
g/l
131.0
133.8
17.92
2135
20875
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
26
159
1.64
1.59
1.2
1.2
u/ml
0.2
0.5
0.59
19
65
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
20
3.00
1.58
3.7
2.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
48
339
1.42
1.55
1.3
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
27
168
1.61
1.55
2.1
2.6
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
13
64
2.04
1.54
1.5
2.6
%
140.0
144.8
0.11
13
59
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
15
3.34
1.52
1.0
2.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
27
2.60
1.51
1.3
3.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
16
86
1.87
1.50
3.9
2.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
25
154
1.63
1.50
1.2
1.4
mmol/l
19.2
12.4
—
8
40
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
65
2.01
1.48
1.5
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
37
2.44
1.48
1.6
3.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
25
155
1.62
1.47
1.3
1.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
32
211
1.52
1.46
2.7
4.5
u/ml
19.6
96.8
1.44
11
61
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
22
132
1.67
1.46
1.5
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
16
87
1.84
1.45
1.3
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
282
2485
1.15
1.45
1.3
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
82
639
1.29
1.44
3.2
3.6
u/ml
17.5
2244.8
0.83
69
554
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
16
3.13
1.44
1.0
1.2
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
14
73
1.92
1.43
2.0
2.2
umol/l
53.9
51.7
—
8
55
(3023323) Follitropin [Units/volume] in Serum or Plasma
142
1181
1.22
1.43
1.4
1.3
iu/l
33.0
30.7
0.32
121
1010
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
22
133
1.66
1.42
1.5
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
203
1747
1.18
1.41
1.5
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
23
141
1.64
1.41
2.4
2.1
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
9
40
2.25
1.40
1.2
1.3
%
0.7
4.4
—
9
34
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
33
222
1.49
1.38
1.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
23
2.61
1.36
1.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
17
2.94
1.36
1.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
49
358
1.38
1.34
2.4
2.9
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
54
2.04
1.32
1.5
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
54
2.04
1.32
1.0
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
46
337
1.37
1.25
1.1
1.1
u/ml
6.0
4.1
0.31
27
163
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
77
1.82
1.25
3.4
2.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
14
77
1.82
1.25
3.7
2.9
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
35
245
1.44
1.23
1.7
1.4
mu/l
49.8
43.1
0.18
30
223
(3006653) Thiamine [Moles/volume] in Blood
17
100
1.71
1.23
1.1
1.4
nmol/l
134.5
133.5
0.03
17
100
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
37
513
0.72
1.22
1.5
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
27
395
0.68
1.20
1.5
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
27
392
0.68
1.16
1.5
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
20
2.50
1.15
2.8
6.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
58
1.90
1.12
1.4
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
80
646
1.25
1.11
1.6
1.3
miu/ml
137.5
223.4
1.86
28
324
(3004451) EKG impression Narrative
13
73
1.79
1.10
1.5
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
21
2.38
1.09
20.2
9.4
mmol/l
5.5
6.0
—
5
21
(3002523) Influenza virus A Ag [Presence] in Specimen
42
312
1.35
1.08
1.1
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
32
2.19
1.08
1.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
35
478
0.73
1.08
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
35
477
0.73
1.06
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
35
476
0.73
1.05
1.4
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
91
751
1.22
1.05
2.2
2.1
u/l
5199.4
4245.6
0.08
26
310
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
211
1870
1.14
1.05
3.0
4.1
ug/l
3.1
23.6
3.46
160
1492
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
35
475
0.73
1.04
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
29
405
0.71
1.03
1.6
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
9
47
1.92
1.02
1.1
2.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
12
68
1.77
1.00
1.5
3.1
umol/l
65.7
182.9
—
6
41
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
109
0.46
1.00
22.0
12.0
nmol/l
649.2
847.2
—
5
104
(3008401) Mugwort IgE Ab [Units/volume] in Serum
43
326
1.33
0.99
1.1
1.1
u/ml
0.2
1.3
1.79
20
133
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
15
92
1.63
0.97
1.7
1.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
9
50
1.80
0.96
1.2
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
12
69
1.74
0.96
15.5
11.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
31
227
1.37
0.90
1.2
1.4
pmol/l
316.4
307.8
0.05
26
181
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
17
110
1.55
0.90
1.4
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
50
394
1.28
0.89
4.4
3.7
mg/l
28.9
24.7
0.38
37
249
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
29
2.07
0.89
1.3
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
6
30
2.00
0.87
2.5
1.6
mmol/l
1.2
1.2
—
6
30
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
30
2.00
0.87
4.5
9.7
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
13
80
1.63
0.84
4.2
2.2
mmol/l
9.2
9.7
—
6
64
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
14
88
1.59
0.84
1.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
45
1.78
0.84
1.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
40
310
1.30
0.82
1.1
1.1
—
—
—
0
0
(4281824)
18
261
0.69
0.82
1.2
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
65
1.70
0.82
1.2
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
17
113
1.51
0.82
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
107
1236
0.86
0.81
1.8
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
33
431
0.76
0.80
1.5
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
67
555
1.21
0.80
2.2
2.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
29
385
0.75
0.79
1.7
1.7
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
33
1.82
0.79
5.2
9.4
—
—
—
0
0
(4024509)
26
191
1.37
0.77
1.2
1.6
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
91
1.54
0.75
1.4
1.8
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
24
2.09
0.74
2.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
146
1299
1.13
0.74
1.9
1.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
19
133
1.43
0.73
1.3
1.9
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
38
1.84
0.73
1.3
2.4
umol/l
21.5
19.2
—
7
38
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
47
379
1.25
0.73
1.1
1.1
u/ml
2.3
1.4
0.22
21
148
(3009542) Hematocrit [Volume Fraction] of Blood
1778
17500
1.07
0.72
25.6
14.0
%
38.9
39.4
1.71
1264
12897
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
310
0.74
0.71
1.8
1.7
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
40
1.75
0.71
1.4
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
40
1.75
0.71
1.0
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
143
1.40
0.70
1.7
2.2
u/field
1.3
2.5
—
9
60
(3033799) Differential panel - Peritoneal fluid
9
58
1.55
0.69
2.3
1.9
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
14
93
1.51
0.69
1.1
1.4
%
—
73.8
—
0
11
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
17
118
1.44
0.69
1.0
1.4
—
679.0
—
0
10
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
12
77
1.56
0.68
1.3
1.6
iu/ml
—
808258.3
—
0
6
(4133840)
7
42
1.67
0.68
1.3
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
28
1.79
0.66
1.0
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
248
2290
1.09
0.65
4.1
4.3
%
36.0
32.7
4.70
191
1548
(40768795) Lymph node Pathology biopsy report
26
198
1.32
0.64
1.5
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
29
1.73
0.64
2.6
2.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
164
0.67
0.61
1.1
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
50
1.60
0.61
1.8
2.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
50
1.60
0.61
1.8
2.9
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
8
52
1.54
0.59
1.1
1.7
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
10
64
1.56
0.58
1.9
1.1
%
—
16.8
—
0
5
(3000034) Microalbumin [Mass/volume] in Urine
21
158
1.33
0.57
2.9
2.6
mg/l
15.2
25.6
0.51
16
114
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
35
283
1.24
0.56
2.0
1.7
nmol/l
53.3
42.5
0.87
35
274
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
120
1078
1.12
0.56
1.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
55
1.46
0.56
1.4
1.3
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
6
37
1.62
0.55
1.2
1.2
—
4.3
—
0
7
(3021387) Prolactin [Units/volume] in Serum or Plasma
78
683
1.15
0.54
1.8
1.6
mu/l
282.1
316.2
0.58
70
615
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
19
142
1.34
0.54
1.6
2.0
nmol/l
15.9
19.1
1.47
19
134
(3029396) Erythrocyte agglutination [Presence] in Blood
6
38
1.58
0.54
4.5
3.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
14
193
0.72
0.53
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1899
18789
1.07
0.52
4.5
4.3
mmol/l
4.6
4.8
9.53
1804
17496
(3028707) Methadone [Presence] in Urine by Screen method
23
293
0.78
0.52
1.3
2.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
50
586
0.85
0.51
1.5
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
40
1.50
0.51
1.2
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
48
408
1.18
0.49
2.4
2.4
ug/min
35.5
102.3
2.38
30
250
(3010726) Horse dander IgE Ab [Units/volume] in Serum
37
307
1.21
0.49
1.1
1.1
u/ml
0.6
2.5
1.91
12
72
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
176
1901
0.92
0.49
1.8
2.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
113
1023
1.11
0.48
1.7
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1887
18682
1.06
0.47
4.5
4.2
mmol/l
1.5
1.5
1.05
1784
17304
(3045683) HLA typing for celiac disease panel - Blood or Tissue
16
120
1.34
0.46
1.0
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1819
17998
1.05
0.45
4.1
3.8
mmol/l
1.2
1.3
2.66
1716
16570
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
98
886
1.11
0.44
1.5
1.4
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
10
69
1.45
0.44
1.6
1.5
pmol/l
15.0
14.1
—
10
57
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
27
220
1.23
0.43
1.1
1.1
u/ml
0.1
0.4
—
9
51
(40758292) HTLV I+II Ab panel - Serum
5
31
1.61
0.43
1.2
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
56
1.43
0.42
1.5
2.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
26
212
1.23
0.42
2.2
2.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
55
626
0.88
0.41
1.3
1.7
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
29
240
1.21
0.41
1.1
1.1
u/ml
2.9
4.2
0.41
16
91
(3016879) Cocaine [Presence] in Urine
51
582
0.87
0.40
1.3
1.8
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
34
1.47
0.40
1.8
1.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
34
1.47
0.40
1.0
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
30
252
1.19
0.38
1.4
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
29
243
1.20
0.37
1.6
1.2
nmol/l
—
—
—
0
0
(3011648) Oxygen content in Venous blood
18
143
1.26
0.37
1.8
2.0
%
11.4
10.8
0.34
18
143
(3028300) Cannabinoids [Presence] in Urine
56
629
0.89
0.36
1.3
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
49
554
0.88
0.35
1.5
1.7
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
43
1.40
0.35
1.0
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
73
805
0.90
0.35
1.7
1.7
mg/l
7.7
3.8
0.63
56
564
(3027944) Amphetamines [Presence] in Urine
55
616
0.89
0.34
1.3
1.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
44
1.36
0.34
1.2
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
133
0.75
0.33
1.1
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
56
624
0.89
0.33
1.3
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
38
434
0.87
0.32
1.3
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
99
0.71
0.30
1.0
1.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1923
19109
1.04
0.28
4.9
4.7
mmol/l
2.7
2.8
11.10
1819
17687
(1001926) Buprenorphine [Presence] in Urine by Screen method
44
489
0.90
0.26
1.3
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
525
5119
1.03
0.26
1.6
1.7
mmol/l
1.3
1.4
0.24
466
4346
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
150
1577
0.95
0.24
2.9
3.0
ug/l
0.7
0.8
0.53
105
1019
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
205
2135
0.96
0.23
1.8
2.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
22
254
0.86
0.23
1.2
1.3
mmol/l
7.1
7.4
0.23
14
182
(3013139) Helicobacter pylori Ag [Presence] in Stool
141
1341
1.05
0.23
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
86
805
1.07
0.23
1.1
1.1
—
—
—
0
0
(44813793)
18
153
1.18
0.22
1.2
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
12
0.00
0.21
0.0
1.0
—
21.8
—
0
7
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
13
0.00
0.21
0.0
1.1
—
8.0
—
0
13
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
280
2715
1.04
0.20
4.4
4.8
ug/l
2.2
2.7
0.45
247
2411
(3039443) Prostate specific Ag panel - Serum or Plasma
14
166
0.84
0.20
1.9
1.6
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
9
112
0.80
0.20
1.2
1.4
mmol/l
5.5
5.9
—
9
107
(3041806) Other cells [#/volume] in Blood by Manual count
6
50
1.20
0.19
1.8
1.6
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
12
99
1.21
0.19
1.0
1.0
—
0.3
—
0
16
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
67
628
1.07
0.18
1.7
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
208
2150
0.96
0.18
1.8
1.7
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
12
100
1.20
0.18
1.3
1.4
nmol/l
1.5
1.2
0.28
12
81
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
197
1906
1.04
0.17
1.5
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
67
0.75
0.17
1.0
1.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
29
263
1.10
0.16
1.1
1.1
u/ml
6.8
3.0
0.34
14
95
(3034274) Bile acid [Moles/volume] in Serum --fasting
27
244
1.11
0.16
2.3
2.1
umol/l
5.4
5.8
0.09
19
170
(3051651) Icteric interference index of Serum or Plasma
13
111
1.17
0.15
3.8
3.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
12
102
1.18
0.15
1.7
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
15
131
1.15
0.14
3.8
6.4
—
—
—
0
0
(4146454)
21
189
1.11
0.13
2.8
2.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
212
2174
0.97
0.13
3.9
4.2
%
22.1
21.2
0.37
96
1007
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
17
152
1.12
0.12
1.9
1.4
g/l
0.8
1.0
1.01
17
152
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
33
308
1.07
0.11
1.1
1.1
iu/ml
72.3
1830.9
—
6
72
(3033705) Calcium.ionized [Moles/volume] in Venous blood
21
193
1.09
0.10
3.8
2.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
57
594
0.96
0.09
1.2
1.3
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
22
236
0.93
0.08
1.1
1.4
ug/l
2.9
4.1
0.42
16
207
(3025130) Human papilloma virus identified in Specimen
32
338
0.95
0.08
2.2
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
46
441
1.04
0.07
5.5
4.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
525
5211
1.01
0.06
1.5
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
24
227
1.06
0.06
1.3
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
120
1.08
0.04
1.2
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
31
298
1.04
0.04
1.5
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
14
133
1.05
0.01
1.6
1.3
—
1.5
—
0
8
(3011288) Drugs identified in Urine by Screen method
41
417
0.98
0.01
1.7
2.5
—
—
—
0
0
(3000012) Reticulocyte production index
10
94
1.06
0.01
1.1
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
97
1.03
0.00
2.7
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
11
107
1.03
0.00
1.6
1.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
26
265
0.98
0.00
3.5
5.4
umol/l
366.7
366.6
0.00
20
228
(4034850)
62
624
0.99
0.00
16.5
9.3
—
—
—
0
0
(4094501)
48
475
1.01
0.00
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
36
364
0.99
0.00
2.1
2.2
nmol/l
0.8
0.8
0.42
29
302
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.4
—
164.6
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013862) HLA-DP [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007733) Chloride [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
90.3
—
0
6
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
15.1
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
108.8
—
0
5
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
54
0.93
0.00
1.0
1.3
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_CONNECTNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_CONNECTNAS | 1.701 [1.54, 1.88] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.266 |
During the follow-up period (1.1.1998 — 31.12.2019), 1412 out of 7588 females with M13_CONNECTNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_CONNECTNAS | 1.857 [1.6, 2.16] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.012 |
During the follow-up period (1.1.1998 — 31.12.2019), 678 out of 2013 males with M13_CONNECTNAS died.
Mortality risk
Mortality risk for people of age
years, who have M13_CONNECTNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.156% | 0.352% |
| 5 | 0.931% | 1.948% |
| 10 | 2.497% | 5.225% |
| 15 | 4.892% | 9.977% |
| 20 | 8.538% | 16.941% |
Relationships between endpoints
↥Index endpoint: M13_CONNECTNAS – Other specified/unspecified systemic involvement of connective tissue
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data